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Abstract  
Mycotoxins are synthesized by fungi and released as secondary metabolites  
toxic to many animal species. The structurally diverse mycotoxins can be 
carcinogenic, mutagenic, teratogenic, estrogenic, hemorrhagic, immunotoxic, 
nephrotoxic, hepatotoxic, dermotoxic, and neurotoxic to humans and other mammals.  
To minimize the harmful effects of mycotoxins on humans, strict regulations have 
been established worldwide. Economic losses due to mycotoxin contamination are 
enormous and estimated at millions of dollars annually in the United States alone 
Insects inevitably encounter mycotoxins in nature when they feed on 
unharvested (mummy) fruits in orchard situations. Insects can be vectors of fungal 
spores and also facilitate fungal access to their host plants. Insects in turn may take 
advantage of fungi for protection against their natural enemies and for processing 
refractory plant constituents to increase their digestibility. This interaction is 
manifested in many crops as an association between insect damage and increase in 
mycotoxin contamination. Control of insects can thus reduce fungal toxin levels in 
crops. Understanding how insects deal with mycotoxins is critical in control of both 
insect pests and mycotoxin contamination.  
In this study, three insects, including Helicoverpa zea (corn earworm), 
Amyelois transitella (navel orangeworm) and Apis mellifera (honey bee) varying in 
their exposure to mycotoxins were selected to study toxicity of mycotoxins to insects 
and to elucidate their underlying mechanisms of toxicity. To compare toxicity of 
mycotoxins to H. zea with that to A. transitella, I measured the developmental delay 
caused by aflatoxin B1 (AFB1), and found that the LC50 (defined as the concentration 
preventing 50% of newly hatched larvae from entering the second instar within 48 hr) 
for AFB1 is 100 times greater for A. transitella than that for H. zea. Similarly, A. 
transitella first instars display substantially higher tolerance of ochratoxin A (OTA) 
than do H. zea. Honey bees and their resource-rich nests are hosts to a wide range of 
saprophytic fungi, including species that produce mycotoxins. Bioassays showed that 
the honey bee workers can tolerate relatively high levels of aflatoxins (1-2.5μg/g 
AFB1) and ochratoxins (1μg/g OTA). 
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Cytochrome P450 monooxygenases (P450s) are critical in detoxification and 
activation of mycotoxins. In this study, I found that midgut homogenates isolated 
from H. zea larvae consuming diets supplemented with phytochemicals (coumarin 
and xanthotoxin) showed significant AFB1 disappearance and generated two 
metabolites, with the primary one identified as aflatoxin P1 (AFP1), an 
O-demethylated less toxic product of AFB1.Three P450 proteins from H. zea 
including CYP6B8, CYP6B27 and CYP321A1 were co-expressed with house fly 
reductase in insect cells and only the expressed CYP321A1 can metabolize AFB1, 
producing the same two metabolites as the midgut homogenates. RT-PCR gel blots 
indicated that the magnitude of CYP321A1 transcript induction by these chemicals is 
associated with the magnitude of increase in the metabolic activities of induced 
midgut enzymes (coumarin>xanthotoxin>indole 3-carbinol). These results indicate 
that induction of P450s, such as CYP321A1, plays an important role in reducing 
AFB1 toxicity to H. zea. Docking of AFB1 in the molecular models of CYP321A1 
and CYP6B8 highlights differences in their proximal catalytic site volumes that allow 
only CYP321A1 to generate the AFP1 metabolite.  
Enhancement of the toxicity of AFB1 by piperonyl butoxide, a P450 
inhibitor, indicates a role for P450s in AFB1 detoxification in honey bees. Extracts of 
propolis, a complex mixture of plant-derived chemicals that contains many 
flavonoids and other phenolic compounds, similarly ameliorated aflatoxin toxicity 
and delayed the onset of mortality. Collectively, these results suggest that tolerance of 
AB1 by honey bees may be due to P450-mediated metabolic detoxification.  
To understand molecular mechanisms underlying detoxification of 
mycotoxins by navel orangeworms, three full-length P450 cDNAs, including 
CYP6AB11, CYP321C1 and CYP6B44, were isolated from larval midguts using 
Rapid Amplification of cDNA Ends PCR. These P450s were co-expressed with house 
fly reductase and fruit fly cytochrome b5 in Sf9 insect cells infected with 
recombinant baculoviruses. Assays conducted with 16 compounds, including AFB1, 
showed that CYP6AB11 can efficiently metabolize imperatorin (0.88pmol/min/pmol) 
and slowly metabolize PBO (0.11 pmol/min/pmol).  
iii 
In view of all of results, it is clear that similar metabolic pathways of 
detoxification of mycotoxins similar to those found in mammals exist in insects. 
However, some insects, such as navel orangeworm, may have evolved in response to 
specializing on food containing mycotoxin-releasing fungi such as navel orangeworm. 
A potentially safe and sustainable approach for managing this serious fungus vector 
in orchards may be to use natural essential oil synergists. My results show that 
myristicin, a natural essential oil compound, synergized the toxicity of 
α-cypermethrin, a pyrethroid insecticide, over time and slightly increased toxicity of 
a plant toxin, xanthotoxin, after seven days. Myristicin should be explored further as 
a field treatment to reduce survival of this pest species and to prevent aflatoxin 
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I. Interactions between insects and mycotoxins 
Abstract 
Mycotoxins are synthesized by fungi and released as secondary metabolites 
which are toxic to many animal species. The structurally diverse mycotoxins can be 
carcinogenic, mutagenic, teratogenic, estrogenic, hemorrhagic, immunotoxic, 
nephrotoxic, hepatotoxic, dermotoxic, and neurotoxic to humans and other mammals. 
Cytochrome P450 monooxygenases (P450s) are critical in detoxification and 
activation of these toxins, and differences in P450 activity lead to variable 
susceptibility among species. Insects inevitably encounter mycotoxins in nature when 
they feed on unharvested (mummy) fruits in orchard situations. These fruits are 
frequently colonized by fungi and the co-occurrence of herbivorous insects with 
fungi has affected their ecology and evolution. Insects can be vectors of fungal spores 
and also facilitate fungal access to their host plants. Insects in turn may take 
advantage of fungi for protection against their natural enemies and for processing 
refractory plant constituents to increase their digestibility.  
With the frequency of encountering mycotoxins varying among species, 
insects have developed variable levels and mechanisms of tolerance. The 
determination of the metabolic pathways of mycotoxins in insects and identification 
of particular enzymes involved will shed light on understanding the factors that 
contribute to variation in tolerance among different insect species and strains. 
Determination of molecular and biochemical mechanisms of detoxification and 
activation of mycotoxins in insects will aid researchers in developing sustainable 
means for managing fungal vectors and will allow farmers to benefit by growing 
insect- or fungus- resistant crop strains or transgenic plants in the future.
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1. Introduction 
Mycotoxins are defined as the chemicals synthesized by fungi and released 
as toxic secondary metabolites. Most mycotoxins are of low molecular weight (<700), 
with highly variable structures. They are usually not involved in fungal growth and 
development. Their toxicity to animals in many cases depends on bioactivation by 
metabolic enzymes. The mycotoxin-releasing molds infect a broad range of plants 
and ingestion of mycotoxins leads to diseases and death for many mammals, poultry 
and fish (Wogan, 1975; Neal, 1995; Hussein and Brasel, 2001; Molyneux et al., 
2007). 
Insects encounter mycotoxins when they consume fungus-infected mummy 
fruits from their host plants. This co-occurrence of herbivorous insects with fungi has 
affected their ecology and evolution. Fungi can be pathogens of insects, with 
infection leading to symptoms such as reduction of feeding, delayed development, 
decreased mating success and even death (Roberts and St Leger, 2004; Scholte et al., 
2004; Pedrini et al., 2007). Fungi can also be symbionts of insects with a mutualistic 
association leading to enhanced digestive efficiency and higher fitness (Brownlie and 
Johnson, 2009; Hartley and Gange, 2009). These two types of interactions arise from 
the generally fortuitous associations between insects and mycotoxin-releasing fungi. 
Insects, themselves, are not hosts for mycotoxin-releasing fungi and both the insect 
and the mycotoxin-releasing fungus may share the same plant host. Insects can serve 
as vectors of mycotoxin-releasing fungi and also facilitate fungal access to their plant 
hosts. Insects in turn may take advantage of fungi for protection against their natural 
enemies and for processing refractory plant constituents to increase their digestibility. 
Long-term trophic association may have promoted co-evolution between 
mycotoxin-releasing fungi and herbivorous insects attacking the same host plants.  
To minimize the harmful effects of myctotoxins on humans, strict 
regulations have been established worldwide. Economic losses due to mycotoxin 
contamination are enormous and estimated at millions of dollars annually in the 
United States alone (Molyneux et al., 2007). Control of insects has been considered 
as an effective method to reduce mycotoxin levels in crops. To summarize the recent 
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research in interaction between insects and mycotoxins, I will discuss mycotoxins 
and their metabolism in animals, describe the association between insect damage and 
mycotoxin contamination in crops, and summarize studies in toxicity of mycotoxins 
to insects and their underlying resistance mechanisms.  
2. Mycotoxins 
Over 300 mycotoxins have been isolated and identified (Betian, 1984) but 
only a small number of mycotoxins known to cause serious diseases in humans and 
other mammals have been studied; these include aflatoxins, ochratoxins, 
trichothecenes, zearalenone, fumonisins, tremorgenic toxins, and ergotoxins (Steyn, 
1995; Hussein and Brasel, 2001; Molyneux et al., 2007). Most of these toxins are 
released by several species of fungi. The most common mycotoxin-releasing fungi 
are Aspergillus species. The structurally diverse mycotoxins can be carcinogenic, 
mutagenic, teratogenic, estrogenic, hemorrhagic, immunotoxic, nephrotoxic, 
hepatotoxic, dermotoxic, and neurotoxic to vertebrates, including humans (Steyn, 
1995). Mycotoxins can cause various chronic or acute diseases depending on their 
different modes of action. Aflatoxins were the first mycotoxins to be identified when, 
in 1960, an aflatoxin releasing-fungus, Aspergillus flavus, infected more than 100,000 
young turkeys in England with high mortality after a few months. The disease was 
initially named “Turkey X disease” (Eaton and Gallagher, 1994; Neal, 1995; Hussein 
and Brasel, 2001) until mycotoxins were identified as the causative agent. Since then, 
toxicity, metabolism and impact of aflatoxins and other mycotoxins on humans and 
other animals have been widely studied.  
In nature, there are four common aflatoxins, including aflatoxin B1, B2, G1, 
and G2. Among them, aflatoxin B1 (AFB1) and B2 (AFB2) are released mainly by A.  
flavus and Aspergillus parasiticus and aflatoxin G1 (AFG1) and G2 (AFG2) are 
released mainly by A. parasiticus. Aflatoxin B1 is most toxic among the four 
aflatoxins and also one of the main carcinogens responsible for human liver cancer 
(Eaton and Gallagher, 1994; Neal, 1995; Hussein and Brasel, 2001). The toxicity of 
AFB1 is typically induced by the metabolic system in liver or lung to form an 
unstable but extremely toxic product, AFB1-epoxide (AFBO), which can cause DNA 
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mutations. Aflatoxins cause acute and chronic toxicity to vertebrates by directly 
damaging tissues, altering vital gene expression and interfering with cell apoptosis 
(Eaton and Gallagher, 1994; McLean and Dutton, 1995; Neal, 1995; Guengerich et. al, 
1998). Studies have also shown that co-occurrence of Hepatitis B virus (HBV) with 
aflatoxin contamination in foods can increase the risk of hepatocellular carcinoma. 
The International Agency for Research on Cancer (IARC) from the World Health 
Organization has classified aflatoxins as Class I toxins (Henry et al., 1999). Aflatoxin 
B1 toxicity varies among species, with the turkey among the most susceptible species 
(Eaton and Gallagher, 1994) while some rodent species are relatively tolerant (Wong 
and Hsieh, 1980).  
Aflatoxins are generally not acutely toxic to humans but their chronic effects, 
especially their carcinogenic effects, make them among the most dangerous natural 
chemicals. Aflatoxin-releasing fungi can infest most commodities and feeds. 
Complete elimination of aflatoxin contamination is not an achievable goal because 
contamination can occur in every stage of food production, including growth, harvest, 
processing, delivery and storage (Park and Troxell, 2002; Cleveland et al., 2003). In 
the United States, the Food and Drug Administration limits total aflatoxin levels to 20 
ppb in all foods and 0.5 ppb AFM1 in milk (Food and Drug Administration, 1996). 
The European Union sets much more stringent regulations, with upper contamination 
limits set at 4 ppb-8 ppb in common foods and 0.05 ppb AFM1 in milk (van Egmond 
et al., 2007). In most developed countries, aflatoxins are primarily an economic and 
not a health problem. However, in some developing countries, especially in Africa 
and Asia, aflatoxins may cause death with long time exposure. The occurrence rate of 
liver cancer is significantly higher in developing nations and is associated with the 
combined effects of high frequencies of hepatitis B viral infection and daily diets 
containing high levels of aflatoxins in these areas (Henry et al., 1999; Suriawinata 
and Xu, 2004; Williams et al., 2004). 
In addition to aflatoxins, Aspergillus species, as well as some Penicillium 
species, produce another class of mycotoxins, the ochratoxins. Ochratoxin A (OTA), 
the most widespread and toxic compound in this group, is known for its nephrotoxic 
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effects in poultry and is considered a potential human carcinogen (Dirheimer and 
Creppy, 1991; Marin-Kuan et al., 2008). The sesquiterpene trichothecenes constitute 
another group of mycotoxins, produced by various fungi, including species in the 
genera Fusarium, Myrothecium, Trichoderma, Trichothecium, Cephalosporium, 
Verticimonosporium, and Stachybotrys. T-2 toxin, the most toxic trichothecene, is 
produced mainly by Fusarium species. It owes its toxicity to vertebrates to its ability 
to inhibit DNA and RNA synthesis, causing cytotoxicity, cell damage and immune 
system changes (Steyen, 1995; Sokolović et al., 2008). Zearalenone, yet another 
mycotoxin, is a potent phytoestrogenic compound synthesized by several Fusarium 
species that can cause infertility, abortion or other reproductive problems. Fumonisins 
(B1 and B2) are potential carcinogens and metabolites of F. proliferatum and F. 
verticillioides, which frequently infect maize, wheat and other grain crops. Fumonisin 
B1 can cause esophageal cancer and neural tube defects in humans and also cause 
equine leukoencephalomalacia and porcine pulmonary edema (Steyen, 1995; 
Stockmann-Juvala and Savolainen, 2008). Most tremorgenic toxins (Selala et al., 
1989) are produced by molds from the genera Penicillium and Aspergillus and can 
damage the central nervous system (CNS). Ergotoxines are mixtures of alkaloids 
identified from the ergot fungus Claviceps purpurea that can produce intensive 
generalized vasoconstriction of blood vessels in human (Bangh et al., 2005).  
3. Metabolism of aflatoxins  
Although the metabolic breakdown of mycotoxins has been studied in a 
wide range of animals, only that for aflatoxins has been elucidated. Among enzymes 
responsible for the biotransformation of aflatoxins across species are cytochrome 
P450 monooxygenases (P450s), a ubiquitous superfamily of heme proteins that 
enzymatically use NADPH and or/NADH to reductively split molecular dioxygen, 
binding one oxygen to the substrate and forming water with the other oxygen atom 
(Feyereisen, 1999). The multiplicity and diversity of P450s allow them to metabolize 
a wide range of chemicals, including steroid hormones, fatty acids, phytochemicals, 
pollutants and carcinogens (Feyereisen, 1999; Stegeman and Livingstone, 1998; 
Shuler and Werck-Reichhart, 2003; Li et al., 2007). Mammalian P450s have long 
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been associated with the biotransformation of aflatoxins (Fig. 1). Oxidation of AFB1 
leads to formation of multiple polar metabolites, including aflatoxin M1 (AFM1), 
aflatoxin Q1 (AFQ1), aflatoxin B2a (AFB2a) and aflatoxin P1 (AFP1). Aflatoxin M1, 
Q1 and B2a are products of hydroxylation of AFB1 and display lower acute toxicity 
and mutagenicity than AFB1 (Sinnhuber et al., 1974; Hsieh et al., 1984; Raney et al., 
1992). Aflatoxin P1, an O-demethylation product of AFB1, is the main metabolite in 
urine of rats, mice and monkeys exposed to dietary AFB1 (Wong and Hsieh, 1980). 
While P450s generally metabolize xenobiotics into less toxic products, 
occasionally they can bioactivate certain compounds. Aflatoxin B1 is bioactivated by 
P450s to AFBO, which can interact with DNA to form guanyl N7 adducts leading to 
inhibition of DNA synthesis or generation of point mutations that activate 
protooncogenes and inactivate cancer suppressive genes. Activated products can also 
bind with proteins to directly affect the activity of functional enzymes (Eaton and 
Gallagher, 1994; McLean and Dutton, 1995; Guengerich et al., 1998). Phase II 
detoxification enzymes including glutathione S-transferases (GSTs), glucoside 
transferase and cytochrome reductase are also important in the detoxification of 
aflatoxins (Fig. 1). GST-mediated conjugation of AFBO with reduced GSH is a major 
pathway to detoxify AFB1 in many mammals. GST acts by conjugating glutathione 
(GSH) to electrophilic substrates to generate more hydrophilic and more excretable 
metabolites (Hayes et al., 2005). In rodents, susceptibility to AFB1 is inversely 
associated with GST activity in liver toward AFBO (Lotlikar et al., 1984; Monroe and 
Eaton; 1988; Buetler et al., 1992). Aflatoxin B1 can be converted to aflatoxicol (AFL) 
by aflatoxin B1 aldehyde reductase (AFAR) and converted back to AFB1 by a 
dehydrogenase (Eaton and Gallagher, 1994).  
4. Association between insect damage and mycotoxin contamination in crops 
Insect damage has long been associated with increased mycotoxin 
contamination in crops. Fruits with enclosed seeds are particularly suitable habitats 
for mycotoxin-producing fungi following herbivory by such insects as Helicoverpa 
zea, the corn earworm, Pectinophora gossypiella, the pink bollworm and Amyelois 
transitella, the navel orangeworm (Widerstrom, 1979). In addition, some other 
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insects such as Elasmopalpus lignosellus (the cornstalk borer), Diabrotica 
undecimpunctata howardi (the corn rootworm), Microtermes spp (termite), and other 
non-insect animals such as mites and nematodes also contribute to Aspergillus 
infection in plants (Widstrom, 1979).  
H. zea (Lepidoptera: Noctuidae), the corn earworm, is a significant 
facilitator of mycotoxin contamination of maize. It has a wide range of host plants 
and is a serious pest in North America (Neunzig, 1963; Archer et al., 1994; Capinera, 
2001). Of over 100 host plants, many, such as corn and cotton, are frequently infected 
by Aspergillus fungi. In the case of maize, larvae eat corn silk initially, and then 
damage kernels. Wounds can facilitate fungal access into the ear (Widstrom, 1979). 
Many lines of evidence indicate a causative association between insect infestation 
and mycotoxin contamination. Higher levels of aflatoxin are detected in corn 
damaged by insects than in undamaged corn (Anderson et al., 1975; Lillehoj et al., 
1976); kernels with thick pericarps typically have lower levels of aflatoxins (Calvert 
et al., 1978); and mechanically damaged ears are more likely to be infected by fungi 
(Lillehoj et al., 1979).   
Effective insect control is one way to reduce crop contamination by 
mycotoxins. Control of H. zea with insecticide application led to reductions in 
aflatoxin contamination in corn (Widstrom et al., 1976). Hostplant resistance to 
insects is regarded as an economic way to reduce aflatoxin contamination. The use of 
transgenic Bt crops resistant to insects reduces both the direct damage by insect 
feeding and aflatoxin contamination of crops (Dowd, 2001; Buntin et al., 2004; Wu et 
al., 2006). Application of transgenic Bt crops prevents attacks from H. zea and also 
has decreased aflatoxin contamination (Dowd, 2001; Buntin et al., 2004; Wu, 2006). 
Tex6, a maize inbred strain with resistance to both insect damage and Aspergillus, is a 
particularly promising tool for managing mycotoxin contamination (Dowd and White, 
2002).  
5. Toxicity of mycotoxins to insects  
Mycotoxins can cause toxicity to insects, including insecticidal effects 
and developmental delay (Zeng et al., 2006). There is variable sensitivity of insects to 
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aflatoxin toxicity, initially examined in the fruit fly Drosophila melanogaster. The 
fruit fly is frequently exposed to mummy fruits such as citrus fruits infected with 
Aspergillus fungi (Alderman and Marth, 1976). Ingestion of experimental medium to 
which a high concentration of AFB1, 10 ppm, was added caused death of all newly 
hatched first instar larvae in 8 days (Kirk et al., 1971). Other effects of AFB1 on D. 
melanogaster including egg-to-adult viability, fertility, and crossing over have been 
observed at a lower concentration, 674 ppb, which exceeds the LD50 (Chinnici et al., 
1976). Different wild strains of D. melanogaster also showed variable sensitivities to 
aflatoxins. The strain, Crimea, has a lower egg-to-adult viability than other wild 
strains when fed with 0.4 ppm AFB1 continuously (Llewellyn and Chinnici, 1978) 
and the hybrids of intercrossing of the Lausanne-S, a resistant strain, with Crimea 
strain showed relatively higher resistance to AFB1 measured with egg-to-adult 
viability and developmental time, and pupal case and adult body length (Chinnici et 
al., 1979). Strain variation suggests that AFB1 toxicity is genetically controlled and 
may be regulated by several genes conferring resistance. More interestingly, a 
sensitive strain, Florida-9, was more sensitive to AFG1 than AFB1, in contrast with 
the general pattern that AFB1 is more toxic than other aflatoxins in vertebrates; its 
lower sensitivity may be explained by its lower activity of activation of AFB1 (Gunst 
et al., 1982).  
Aflatoxins also have been tested for their toxicity to larval lepidopterans. 
Toxicity of AFB1 was detected in newly hatched larvae of Heliothis virescens; 10 
µg/g AFB1 can cause 100% mortality in 8 days (Gudauskas et al., 1967). Aspergillus- 
infected diet can cause mortality or growth delay to Bombyx mori, the silkworm 
(Ohtomo et al., 1975). Zeng et al. (2006) described toxicity of AFB1 to H. zea larvae 
at different larval stages. For newly hatched first instar larvae, 20 ng/g AFB1 caused 
50% mortality while a higher concentration, 200 ng/g AFB1, caused 100% mortality. 
Pupal weight of the larvae fed with 1 ng/g AFB1 in diet was significantly decreased 
compared with control insects. Tolerance of AFB1 increases with larval stages. The 
third instar larvae can tolerate 20 ng/g AFB1 with only moderate reduction of pupal 
weight while 200 ng/g AFB1 significantly affected mortality, pupation rate and pupal 
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weight. For the fifth instar larvae, the concentration of 200 ng/g only delayed 
development without affecting mortality, pupation rate, or pupal weight, whereas 1 
µg/g AFB1 reduced pupal weight by 29.3% and pupation rate by more than one-third. 
Malformation of pupae was found after the fifth instar larvae were exposed to 1µg/g 
AFB1 and the pupae failed to develop (Zeng et al., 2006).  
6. Detoxification mechanism of mycotoxins by insects  
Depending on the susceptibility of plants to Aspergillus infection, insects 
feeding on these plants encounter mycotoxins with variable frequency. How insects 
cope with mycotoxins has rarely been investigated. Insects have developed various 
mechanisms to deal with plant toxins (Ma et al., 1994; Hung et al., 1997; Li et al., 
2004; Mao et al., 2006) and insecticides (Feyereisen, 1999; Sasabe et al., 2004; Li et 
al., 2007), with the most important mechanism being metabolic detoxification that 
generally involves two phases. In phase I, a functional group is usually added to the 
parent compound which is then conjugated to very water-soluble moieties such as 
glucuronic acid, sulfate, glutathione and others. Through these two phases, a 
lipophilic toxin is generally transformed into a more hydrophilic compound and 
excreted.  
Up to twelve metabolites were observed in metabolism reactions carried out 
in vitro with tested tissue of different strains of D. melanogaster and the metabolites 
were identified as AFM1, AFB2a and AFL, with AFL as the primary metabolite 
among them (Foerster and Wurgler, 1984). Lee and Campbell (2000) found three 
metabolites of AFB1 produced by larvae of the navel orangeworm, including chiefly 
AFL and minor amounts of AFB2a and AFM1. Zeng et al. (2006) has demonstrated 
that P450s might be involved in both detoxification and bioactivation in H. zea. With 
addition of piperonyl butoxide (PBO), a general and effective inhibitor of P450s in 
many different taxa, to diet containing 1μg/g concentration of AFB1, toxicity of 
AFB1 to fourth instar larvae of H. zea was significantly decreased. Pupation rate 
significantly increased from 0% for larvae feeding on diet containing AFB1 alone to 
71.7% for larvae feeding on diet containing both AFB1 and PBO. The fact that 
inhibition of P450 activity significantly decreases the toxicity of AFB1 indicates that 
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AFB1 is bioactivated to more toxic derivatives via one or more P450s in H. zea. On 
the other hand, fifth instar larvae exposed to both AFB1 and phenobarbital, a P450 
inducer, significantly increased pupal weight compared with larvae feeding on the 
diet containing AFB1 alone. This finding suggests that induced P450s are responsible 
for the decrease in toxicity (Zeng et al., 2006). Saccharomyces cerevisiae transformed 
with fruit fly CYP6A2 cDNA and human NADPH-cytochrome P450 reductase has 
shown induced gene conversion when treated with AFB1, indicating that AFB1 
might be activated to release its genetic toxicity (Saner et al., 1996). Similar 
metabolic pathways of detoxification and activity of aflatoxins in mammals may also 
exist in insects. Determination of molecular and biochemical mechanisms of 
detoxification and activation of mycotoxins in insects will aid researchers in 
developing sustainable means for managing fungal vectors and will allow farmers to 
benefit by growing insect- or fungus-resistant crop strains or transgenic plants in the 
future. 
7. Summary  
Mycotoxins are the ecological consequence of fungal adaptation to 
environmental challenges. Plants susceptible to fungus infection may produce 
mummy fruits with high concentrations of mycotoxins. Insects can greatly increase 
the infection rate by providing access routes for fungi and increase mycotoxin 
accumulation in these fruits. Co-evolution may have occurred in specific interactions 
between mycotoxin-releasing fungi and insects. Other than basic research, studies of 
interactions between insects and mycotoxins can contribute to agricultural 
applications. With concerns about health problem and economic losses due to 
mycotoxin contamination, people are looking for ways to prevent fungal infection in 
crops and to reduce mycotoxin levels in contaminated foods (Mishra and Das, 2003); 
understanding the interactions between insect damage and mycotoxin contamination 
can shed light on ways in which host plant resistance or transgenic plants can be 
employed to resolve both problems. Determination of the molecular and biochemical 
mechanisms of detoxification and activation systems of mycotoxins in insects will 
help researchers to understand how to control these fungal vectors and allow farmers 
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to gain benefits by growing insect- or mycotoxin-resistant crop strains or transgenic 
plants in the future.  
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 Fig. 1 Detoxification and bioactivition of aflatoxin B1. (Eaton and Gallagher, 1994; 



















II Comparative toxicity of mycotoxins to navel orangeworm (Amyelois 
transitella) and corn earworm (Helicoverpa zea) 
Abstract 
Mycotoxins, such as aflatoxins and ochratoxins, are widely distributed in 
nature and are frequently problematic crop contaminants causing millions of dollars 
of annual losses in the United States. Insect infestations of crop plants significantly 
exacerbate mycotoxin contamination. Damage to a variety of nut species by Amyelois 
transitella Walker (navel orangeworm, NOW) is associated with infection by 
Aspergillus species and concomitant production of aflatoxins and ochratoxins. 
Resistance to aflatoxins in this lepidopteran is compared here with the levels of 
resistance in Helicoverpa zea (corn earworm, CEW), another lepidopteran that 
routinely encounters aflatoxins in its diet, albeit at lower levels. Measured as the 
developmental delay caused by aflatoxin B1, it is apparent that the LC50 (defined as 
the concentration preventing 50% of newly hatched larvae from entering the second 
instar within 48 hr) for AFB1 is 100 times greater for A. transitella than for H. zea. 
Similarly, A. transitella first instars display substantially higher tolerance of 
ochratoxin A, another mycotoxin contaminant produced by Aspergillus species, than 
do H. zea. Our studies indicate that A. transitella, although a hostplant generalist, 














The navel orangeworm Amyelois transitella (Walker) (NOW: Lepidoptera: 
Pyralidae) is a serious crop pest that attacks almonds, pistachio, walnuts, peanuts and 
figs, causing millions of dollars of agricultural damage in the United States (Burks 
and Brandl, 2004; Campbell et al., 2003; Connell, 2001). Damage results from 
consumption of the nutmeat and contamination of the nut with webbing and frass. In 
addition to causing such direct losses, the feeding damage caused by NOW 
predisposes almonds to infection by Aspergillus spp., which produce toxic aflatoxins 
and ochratoxins. Particularly susceptible are soft-shelled cultivars with an extended 
split hull period (Schade et al., 1975; Schatzki and Ong, 2000, 2001). The occurrence 
of fungal contamination in pistachio, almond, peanut and figs is also closely 
associated with the extent of NOW damage (Campbell et al., 2003; Schatzki and Ong, 
2000, 2001; Widstrom, 1979). Aflatoxin contamination has tremendous trade 
implications inasmuch as export to Europe is restricted based on minimum levels 
(Otsuki et al., 2001).  
Aflatoxins are synthesized by A. flavus and A. parasiticus, with aflatoxins 
B1, B2, G1 and G2 most commonly produced (Cleveland et al., 2003). Of these, 
aflatoxin B1 (AFB1) causes a number of serious health problems in humans 
including acute and chronic toxicity to humans and mammals by directly damaging 
tissues, mutating important genes, inducing and inhibiting other vital gene expression 
and interfering with cell apoptosis (Eaton and Gallagher, 1994; Guengerich et. al, 
1998; McLean and Dutton, 1995; Neal, 1995). Economic losses due to aflatoxin 
contamination are enormous and estimated at millions of dollars in the US alone each 
year. To minimize the harmful effects of aflatoxins, strict regulations have been 
established in the US. While crops and finished food products containing aflatoxins 
above 20 ppb are not allowed for human consumption, the limitation is set at 5ppb for 
milk (Cleveland et al., 2003; Williams et al., 2004). Ochratoxins are produced 
primarily by two other fungi, A. ochraceus and Penicillium verrucosum. Ochratoxin 
A (OTA) is capable of interfering with immune system function (Neal, 1995) and 
may also be carcinogenic. Because of these properties, commodities contaminated 
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with high concentrations of mycotoxins (e.g., 20 ppb for aflatoxins) are blocked from 
sale both in the U.S. and overseas (Bayman and Baker 2006; Park and Troxell, 2002). 
Without appropriate monitoring measures, mycotoxin-contaminated food has had 
serious impacts on human health in many areas, especially in developing countries in 
Asia and Africa (Williams et al., 2004). 
The level of tolerance to mycotoxins in insects varies from several ppb to 
several ppm and is both species- and sex-specific (Chinnici et al., 1976; Chinnici and  
Llewellyn, 1979; Gudauskas et al., 1967; Kirk et al., 1971; Llewellyn and  Chinnici 
1978; ; Zeng et al., 2006). Larvae of Drosophila melanogaster, which feed naturally 
on fermenting fruits, exhibit significantly altered development on diets with low 
concentrations of AFB1 (less than 1 ppm) and on higher concentrations will die 
(Chinnici et al., 1976; Chinnici and Llewellyn, 1979; Kirk et al., 1971; Llewellyn and  
Chinnici 1978. The corn earworm, Helicoverpa zea (CEW), another species that 
encounters mycotoxin-releasing fungi in damaged plants (Archer and Bynum, 1994; 
Widstrom et al., 1976; Widstrom, 1979), is also tolerant of aflatoxins to some degree. 
Low concentrations of AFB1 in the diet of first instars (less than 100 ng/g) can affect 
development, causing delayed pupation and reduced pupal weight; higher 
concentrations of AFB1 (200 ng/g) are lethal (Zeng et al., 2006). 
The toxicity of aflatoxins to insects depends on their metabolism as 
mediated by cytochrome P450 monooxygenases (P450s, Phase I detoxification 
enzymes) into bioactive products. One of the most toxic of these is the 
AFB1-exo-epoxide, which is derived from AFB1; this bioactivated metabolite of 
AFB1 exo-8,9-epoxide (AFBO) can bind directly to proteins and DNA and cause cell 
death (Eaton and Gallagher, 1994; Guengerich et al., 1998; McLean and Dutton, 1995; 
Suriawinata and Xu, 2004). Glutathione-S-transferases (GSTs, Phase II detoxification 
enzymes) conjugate glutathione to the lipophilic products of P450-mediated 
metabolism to form water-soluble metabolites that are more readily excreted (Hayes 
et al., 2005). In rodent livers, susceptibility to AFB1 is inversely associated with GST 
activity toward AFBO (Buetler et al., 1992; Lotlikar et al., 1984; Monroe and Eaton, 
1988). Another biotransformation of AFB1 is its direct reduction by 
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NADPH-dependent aflatoxin B1 aldehyde reductases (AFAR) to form aflatoxicol 
(AFL), but this product is rapidly converted back to AFB1 by dehydrogenases (Eaton 
and Gallagher, 1994). Alternative biotransformation pathways that generate 
detoxified metabolites, such as aflatoxicol, aflatoxin M1 and aflatoxin B2a, and do 
not generate bioactivated epoxidized metabolites also exist in NOW and contribute to 
the high aflatoxin tolerance of this species (Lee and Campbell, 2000). 
Characterization of similar biotransformation pathways in CEW indicate that at least 
one P450 in this species, specifically CYP321A1, is capable of converting AFB1 into 
polar metabolites, with the demethylated product aflatoxin P1 (AFP1) as the principal 
metabolite (Niu et al., 2008).  
Given the existence of alternative biotransformation pathways in both NOW 
and CEW, we initiated a series of studies to compare toxicity and tolerance of 
mycotoxins in these two species. Because NOW is regularly associated with 
fungus-contaminated hostplant tissue, we hypothesized that its level of tolerance to 
both aflatoxins and ochratoxins should exceed that of CEW, which only occasionally 
encounters fungal contamination inasmuch as it feeds on fruits before they fall to the 
ground. 
2 Methods 
2.1 Chemicals  
Piperonyl butoxide (PBO) was purchased from Tokyo Kassie Kogyo (Tokyo, 
Japan). Aflatoxins B1, G1 and M1, and ochratoxin A were purchased from Sigma 
Chemicals (St. Louis, MO). Analytical grade dimethyl sulfoxide (DMSO) was 
obtained from Fisher Scientific (Pittsburgh, PA). All chemicals were dissolved in 
DMSO to make stock solutions and were stored at -20o C. 
2.2 Insects   
A laboratory colony of H. zea originating from specimens collected in 
Champaign County, IL and a colony of A. transitella originating on almond trees in 
Fresno, CA, which have been maintained in culture for the past 25 years by the 
Commodity Protection and Quality Unit, USDA/ARS, Parlier, CA, were kept in an 
insectary at UIUC at 28 ± 4° C with 16-hr light/8-hr dark cycles. H. zea larvae were 
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reared individually from egg hatch in 5 oz (142 g) plastic cups containing 
approximately 5 g control or supplemented diet. A. transitella larvae were 
mass-reared until pupation in 500 ml plastic containers containing 200 g of wheat 
bran diet (Tebbetts et al. 1978).  
2.2 Bioassays 
Stock solutions of AFB1 or OTA were prepared in DMSO and could be 
stored in –20 ° C for two months. To make the diets containing 1, 5, 10, 20, 50 and 
100 µg/g of AFB1, 100 µl or 500 µl of 1 mg/ml of AFB1 stock solution were 
incorporated into 100 g of the diet to make 1 µg/g or 5 µg/g of AFB1 diet in 0.5% 
DMSO; 50, 100, 250 and 500 µl of 20 mg/ml of AFB1 stock solution were added to 
100 g of the diet to make 10, 20, 50 and 100 µg/g of AFB1 diets in 0.5% DMSO. For 
low concentrations of AFB1 diets containing 20, 40, 60, 80, 100, 120, 140 ng/g of the 
AFB1 diets, 20, 40, 60, 80, 100,120, 140 µl of 100 µg/ml AFB1 stock solution were 
added into 100 g of the diet in 0.2% DMSO. To prepare OTA diets, 50 or 250 µl of 1 
mg/ml OTA stock solution were incorporated into 100 g of the diet in 0.25% DMSO 
to make 1 or 5 µg/g of the OTA diet; 50, 100, 250 µl of 20mg/ml OTA were added 
into 100 g of the diet in 0.25% DMSO to make 10, 20, 50 µg/g of the OTA diet. Pilot 
experiments determined that concentrations of DMSO at levels as high as 0.5% of the 
diet do not affect development or survivorship in either NOW or CEW. 
To assess the toxicity of AFB1 to NOW, six concentrations of AFB1 (1, 5, 10, 
20, 50 and 100 µg/g) diets in 0.5% DMSO solution were prepared and twenty 
neonates (i.e., newly hatched first instars) were placed individually into 142-g plastic 
cups containing 0.5 g unamended diet or supplemented diet prepared with a final 
concentration of 0.5% DMSO. Two higher concentrations of AFB1 (50 and 100 µg/g ) 
diets were fed to 20 ultimate (fifth) instars with the 0.5% DMSO as control. 
Observations of these larvae were made until pupation and pupal weights were 
measured within 48 hr after the final larval molt. Each set of bioassays was replicated 
three times.   
The toxicity of OTA to NOW larvae was tested as for AFB1 with diets 
containing 1, 5, 10, 20 or 50 µg/g OTA at a final concentration in 0.25% DMSO; 
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twenty first instars in each group were treated.  The proportions of dead larvae on 
the 12th day were recorded and each larva on the 14th day was weighed. The pupation 
rate was measured within 48 hours of pupation. To test the toxicity of OTA to CEW, 
first instars were exposed to the diets at concentrations of 0.25% DMSO, 1 or 5 µg/g 
OTA and control diet. The survivorship of larvae at 12 days post-hatch on diets and  
frequency of fifth instars at 12 days post-hatch were recorded.  
To compare the effects of AFB1 on the development of NOW and CEW, first 
instar of CEW larvae were fed with artificial diets containing 0.2% DMSO or 10, 20, 
40, 60, 80, 100, 120 or 140 ng/g AFB1 while first instar A. transitella were fed with 
artificial diets containing 0.2% DMSO,1, 5, or 10 µg/g AFB1. For each species, the 
numbers of larvae reaching second instar were recorded within 48 hr.  
2.3 Midgut protein preparations  
To obtain sufficient midgut tissue from larvae, guts were dissected from at 
least 100  ultimate instars that had molted within the previous 12 hr. Midgut 
dissections were performed in 0.1 M phosphate buffer and on ice and then the 
midguts were frozen in liquid nitrogen and stored at -80°C until use. For each midgut 
preparation of ultimate instars, approximately 40 frozen midguts were ground in a 
mortar in the presence of liquid nitrogen, transferred into a 1.5 ml Eppendorf tube, 
suspended in 1.5 ml 0.1 M phosphate buffer (pH 7.4), 1 mM EDTA, 0.5 mM PMSF, 
0.1 mM DTT, 20% glycerol and then gently shaken for 5 sec. These midgut 
homogenates were centrifuged for 10 min at 10,000 rpm in an Eppendorf centrifuge 
at 4°C and the cleared supernatant was transferred into a new 1.5 ml Eppendorf tube 
and either used immediately or frozen in liquid nitrogen and stored at -80°C for up to 
six months. Protein concentrations for these cleared lysates were determined using 
Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA). 
2.4 In vitro metabolism assays 
For all assays, the frozen cleared lysates were taken from the -80°C freezer 
and thawed on ice for approximately 30 min before the metabolism assays were 
initiated. AFB1 and OTA metabolism assays were carried out as described previously 
in Lee and Campbell (2000) with only slight modifications. Stock solutions of AFB1 
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or OTA at concentrations of 10 µg/g were prepared in DMSO. Each 250-µl reaction 
contained 1µl AFB1 or OTA stock (10 µg/µl), 5 mM reduced glutathione, 1 mg/g 
protein, 0.1 mmol/L sodium phosphate buffer (pH 7.4) and 1 mM EDTA and was 
initiated with the addition of 50 µl of 3 mM NADPH. After a 60-min incubation at 
30°C with shaking, 1 ml of ice-cold methanol containing 10 µM AFG1 (internal 
standard) was added to each reaction to terminate it. The reactions were then 
centrifuged at 10,000xg for 10 min in an Eppendorf centrifuge and each supernatant 
was transferred into a new 1.5 ml Eppendorf tube for analysis by high-pressure liquid 
chromatography (HPLC). All reactions were performed at least twice in triplicate. To 
trap the AFB1-exo-epoxide metabolite, mouse liver cytosol (10 μl, 50 mg/ml) was 
added into reactions containing NOW crude proteins. Reactions were stopped after 
incubation at 30°C for 1 hr and 10 μl of each supernatant were analyzed by HPLC.  
AFB1 and its metabolites were separated on a reverse phase Supercosil 
LC-18 column (250 mm × 4.6 mm) on an HPLC system equipped with a photodiode 
array UV detector (Waters Novapak). Separation of AFB1 and products was achieved 
with water/methanol/acetonitrile (60/20/20) at a flow rate of 1 ml/min and monitoring 
at 362 nm. Under these conditions, AFG1 was eluted at 10.6 min and AFB1 was 
eluted at 14.6 min. Separation of OTA was achieved with acetic 
acid/methanol/acetonitrile (1/49/49) at a flow rate of 1 ml and monitoring at 333 nm; 
under these conditions, OTA was eluted at 10.4 min.   
2.5 Statistics  
All data were analyzed by one-way ANOVA analysis with a post-hoc Tukey 
test at a significance level of p < 0.05.  
3. Results  
3.1 Toxicity of aflatoxin B1 and ochratoxin A to NOW larvae 
A. transitella larvae tolerated very high levels of AFB1 in their diet, with 1, 
5, 10 and 20 µg/g AFB1 having no apparent toxic effects on first instars (Table 1).  
On the diets containing 10 µg/g and 20 µg/g AFB1, pupation rates were 77% and 
78%, respectively, which did not differ significantly from pupation rates on control 
DMSO diet, and there was no significant difference in pupal weights between diets 
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containing 10 µg/g and 20 µg/g AFB1 and control diets. On the diet containing 50 
µg/g AFB1, larval development was delayed and only 55% of the larvae successfully 
pupated, a rate significantly lower than the rate on the control diet (p < 0.05). At the 
extremely high AFB1 concentration of 100 µg/g, development of first instar A. 
transitella was severely inhibited, although 30% of the treated larvae survived for at 
least 3 weeks. Exposure of later stage larvae to diets containing varying 
concentrations of AFB1 showed that their tolerance to AFB1 increased with 
developmental stage; ultimate instars tolerated 100 µg/g AFB1 with no significant 
decreases in pupation rate compared to control larvae fed diets containing 0.5% 
DMSO (Table 2).  
Similarly, A. transitella first instars also displayed great tolerance to OTA, 
with concentrations less than 10 µg/g having no detectable toxic effects (Table 3). At 
higher OTA concentrations (20 µg/g), there were no significant differences in 
mortality rates and larval weight after 14 days. Compared with control larvae fed 
diets containing 0.25% DMSO, A. transitella fed with the highest concentration of 
OTA (50 µg/g) experienced slight toxic effects on development, as evidenced by 
lower larval weights; larval weights after 14 days were significantly lower than those 
of larvae fed control diet (p = 0.047). The highest concentration of OTA (50 µg/g) did 
not significantly lower the pupation rate (Table 3).  
3.2 Comparison of the toxicity of OTA and AFB1 to CEW and NOW  
To compare the toxicity of AFB1 in A. transitella and H. zea, the effects of 
AFB1 on first instars of these two species were measured as described. The LC50 
(defined as the concentration preventing 50% of newly hatched larvae from molting 
to second instar within 48 hr) for AFB1 is 100 times greater for A. transitella than for 
H. zea (Fig. 1). After 48 hr, 60 ng/g AFB1 allowed 50% of first instar H. zea to 
develop into second instars while 10 µg/g AFB1 allowed 80% of first instar A. 
transitella to develop to second instars, a greater than 100-fold difference in 
tolerance. 
Comparisons of the toxicity of OTA to A. transitella and H. zea also revealed 
considerably greater resistance to OTA in A. transitella. Development of first instar A. 
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transitella was not affected by concentrations as high as 1 and 5 µg/g OTA (table 3). 
These concentrations significantly inhibited the development of first instar H. zea 
compared with control larvae, with 10% or no fifth instars appearing after 12 days on 
1 or 5 µg/g OTA-supplemented diets and 40% fifth instars appearing on the 0.25% 
DMSO control diet (p = 0.032 or 0.015, respectively) (Fig. 2b).  
 3.3 Metabolism of AFB1 and OTA by NOW 
To investigate the ability of A. transitella to metabolize AFB1, in vitro 
metabolism experiments were conducted with cleared midgut lysates quantified 
based on total protein. In reactions initiated with NADPH (as outlined in Materials 
and Methods), two polar metabolites of AFB1 (Met1 with retention time of 7.8 min 
and Met2 with retention time of 8.0 min) were readily detected by HPLC analysis 
(Data not shown). Compared with H. zea midgut lysates, A. transitella midgut lysates 
have much higher turnover rates (32 pmol/min/mg total protein vs. 0 pmol/min/mg 
total protein). In contrast, CEW midguts show no activity toward AFB1 unless they 
were induced by prior exposure to coumarin and xanthotoxin (Niu et al., 2008).   
 In an attempt to trap reactive AFBO intermediates, mouse liver cytosol was 
added to some in vitro reactions but no additional metabolite peaks were detected 
(data not shown). This finding is consistent with the suggestion that AFB1 is 
detoxified, and not bioactivated, as the result of hydroxylation by midgut proteins. 
Comparable reactions conducted with OTA showed no metabolism of OTA by A. 
transitella and H. zea lysates either at the level of substrate disappearance or 
metabolite production.  The methods used in this analysis may have been 
insufficiently sensitive to detect metabolism; alternatively, both of these species may 
rely on detoxification in tissues other than midgut, or non-enzymatic means, to 
counter the toxic effects of this compound. 
4. Discussion  
Zeng et al. (2006) and Niu et al. (2008) studied the toxicity and metabolism 
of AFB1 by H. zea, a lepidopteran with tolerance to a broad range of phytochemicals 
but only limited tolerance to aflatoxins even though it occasionally encounters 
aflatoxin-releasing fungi. In contrast, A. transitella, a herbivore that specifically 
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locates and feeds on mummy fruits, is tolerant of extremely high concentrations of 
mycotoxins in its diet. Our studies indicate that A. transitella, although a hostplant 
generalist, may well be highly specialized for mycotoxin detoxification. Indeed, 
recent studies indicate that NOW grows better on fungus-contaminated hostplant 
tissue and may in fact consume fungus tissue as well (Palumbo et al., 2008; personal 
observations).  
In this study, we demonstrated the extremely high tolerance of A. transitella 
to concentrations of AFB1 and OTA and showed that this tolerance exceeds that of 
other mycotoxin-associated species such as H. zea. The concentrations analyzed did 
not kill A. transitella when administered at early developmental stages and caused 
only marginal sublethal effects. Comparisons of the toxicological effects in A. 
transitella and H. zea demonstrated that A. transitella larvae are 100 times more 
tolerant of AFB1 than H. zea and are also significantly more resistant to OTA. The 
ecological consequences of this high tolerance are quite apparent in the high survival 
rates of A. transitella larvae in the mycotoxin-contaminated environments that it 
exploits as a scavenger. The interaction between NOW and Aspergillus species might 
be mutualistic in that the fungus may contribute to maintaining a micro-environment 
that optimizes caterpillar growth and development and the caterpillar may promote 
the dispersal and establishment of the fungus by causing damage that allows fungal 
spores to gain access to fruits (Weis, 1982). Aspergillus species can be cultured from 
adults and the levels are high in adults emerging from Aspergillus-infested substrate 
(JS, unpublished data). 
High tolerance of aflatoxins might be explained by an excess 
detoxification capacity that generates nontoxic metabolites. Both Lee and Campbell 
(2000) and this study demonstrated that no bioactivated metabolites are produced in 
the reactions of NOW proteins. Because AFBO production increases toxicity 
100-fold compared to its parent compound (AFB1) (Eaton and Gallagher, 1994; 
Guengerich et al., 1998; McLean and Dutton, 1995; Suriawinata and Xu, 2004), 
absence of AFBO production by NOW might be a key feature of AFB1 tolerance. In 
contrast with AFB1, there are reports of detoxification of OTA in insects. Although 
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we failed to detect metabolites of OTA by midgut proteins of either H. zea or A. 
transitella, bioactivation is involved in its genotoxicity to other organisms 
(Manderville, 2005; Schaut et al., 2008) and the absence of major pathways 
producing bioactivated metabolites may also reflect adaptation of these insects to the 
presence of this mycotoxin in their diet.  
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Table 1. Pupation rate and pupal weight of A. transitella larvae after exposure to 
different concentrations of aflatoxin B1 (in 0.5% DMSO) at first instar. Values 
for pupation rate are means + standard errors from 20 first instar 
caterpillars/treatment with three experimental replicates for each. Values for pupal 
weight are means of three series of replicates with standard errors.   
 
* indicates that the mean value of this group is significant different from that of the 















Table 2. Toxicity of aflatoxin B1 to ultimate (fifth) instar A. transitella 
Values for pupation rate are means + standard errors from 20 ultimate 
instars/treatment with three experimental replicates for each. Values for larval and 
pupal weight are means of the three series of replicates with standard errors. The data 
were evaluated with one-way analysis of variance (ANOVA) and no differences were 
found in the means of pupation rate or pupal weight among the groups.  
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Table 3. Toxicity of ochratoxin A to first instar larvae of A. transitella 
Values for survival rate are means + standard errors from three replicate bioassays. 
Values for larval and pupal weight are means of the three series of replicates with 
standard errors.  
 
* indicates that the mean value of this group is significant different from that of the 
















Fig. 1 Developmental effects of AFB1 on first instar H. zea and A. transitella.  (A) 
Percentage of H. zea larvae molting to second instar after 48 hr on diets containing 
increasing concentrations of AFB1 and a final concentration of 0.2% DMSO. (B) 
Percentage of A. transitella larvae molting to second instar after 48 hr on diets 



















Fig. 2 Toxicity of OTA to first instar larvae of H. zea. (A) Survivorship of larvae 
12 days post-hatch on diets containing increasing concentrations of OTA and a final 
concentration of 0.25% DMSO. (B) Frequency of fifth instar larvae 12 days 
post-hatch on diets containing 0.25% DMSO, 1 µg/g OTA in 0.1% DMSO or 5 µg/g 





















III Toxicity of mycotoxins to honey bees and its amelioration by propolis 
Abstract 
Honey bees and their resource-rich nests are hosts to a wide range of 
saprophytic fungi, including species that produce mycotoxins. The toxicity of 
aflatoxin B1 (AB1) and ochratoxin A (OTA), products of Aspergillus species often 
found in honey bee hives, was evaluated and LC50 values for both toxins were 
calculated. Workers can tolerate a wide range of concentrations of both OTA and AB1. 
At low concentrations, AB1 (1μg/g and 2.5μg/g diet) and OTA (1μg/g ) did not have 
any apparent toxic effects on bees. Enhancement of the toxicity of AB1 by piperonyl 
butoxide, a known inhibitor of cytochrome P450 monooxygenases (P450s), indicates 
a role for P450s in AB1 detoxification in honey bees. Extracts of propolis, a complex 
mixture of plant-derived chemicals, including many flavonoids and other phenolic 
compounds, similarly ameliorated aflatoxin toxicity and delayed the onset of 
mortality. Collectively, these results suggest that tolerance of AB1 by honey bees may 

















1.  Introduction  
Although honey bees are more sensitive to the toxic effects of the 
mycotoxin aflatoxin B1 than Drosophila melanogaster and Musca domestica 
(Hilldrup and Llewellyn, 1978), the fact that colonies are often able to fend off 
infections is indicative of some capacity for coping with these mycotoxins, which 
may be frequently encountered in the hive environment. In many insect species, 
aflatoxins are metabolized by cytochrome P450 monooxygenases (P450s), 
heme-based enzymes that generally catalyze oxidative reactions that reduce 
lipophilicity and hence toxicity of a wide range of both natural and synthetic 
xenobiotics (Li et al., 2007). Aflatoxins and several other mycotoxins are unusual, 
however, in that in many species P450-mediated metabolic reactions result in 
bioactivation, or an increase in toxicity, via conversion of the aflatoxin to the more 
toxic epoxide metabolite (Saner et al., 1996).   
Species that naturally encounter aflatoxins in their environment display 
some degree of adaptation to mycotoxins in that they metabolize these compounds 
not to bioactivated epoxides but rather to nontoxic breakdown products. The corn 
earworm Helicoverpa zea, for example, frequently causes damage in its hostplants 
that leaves them vulnerable to opportunistic infection by Aspergillus spp. In the 
midgut, H. zea detoxifies aflatoxin B1 (AB1) via CYP321A1 (Niu et al., 2008). Even 
more tolerant of aflatoxins is the navel orangeworm Amyelois transitella. This 
species infests dried fruits and nuts, particularly almonds and pistachios, and appears 
to prefer fungus-infected fruit (Palumbo et al., 2008). This species can tolerate dietary 
levels of AB1 100-fold greater than levels that inhibit H. zea (Niu et al., 2009) and 
produces principally aflatoxicol as a metabolite. Neither this species nor the 
aflatoxin-tolerant codling moth Cydia pomonella produces AB1-8,9-epoxide, the 
principal bioactivated metabolite of AB1 (Lee and Campbell, 2000). Although 
P450-mediated metabolism has been implicated in this tolerance, the specific P450(s) 
responsible for this detoxification have not yet been identified in either species.   
In this study, we set out to ascertain the degree to which A. mellifera can 
tolerate exposure to mycotoxins and to establish whether tolerance is associated with 
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P450-mediated metabolism by using a known inhibitor of honey bee P450s, 
piperonyl butoxide (PBO), and a known inducer of honey bee P450s, propolis, the 
resinous “bee glue” that is a ubiquitous component of the hive; Johnson (2008) 
demonstrated that extracts of propolis administered orally to honey bees effects 
upregulation of three CYP6AS P450 genes, at least one of which is known to 
metabolize flavonoids found in honey, pollen and propolis (Mao et al. 2009).  
Understanding the mechanisms of resistance to mycotoxins may shed light on how 
this managed pollinator copes with chemical stresses.  
2.  Materials and Methods 
2.1 Insects  
Honey bees were obtained from colonies containing multiply mated 
queens at the University of Illinois Bee Research Facility at Urbana (Champaign 
County), IL. Frames of late-stage pupae were taken from hives and transferred to a 
dark humid incubator at 32-34o C. Newly eclosed adults were brushed from frames 
every 24 hours for immediate use in bioassays. 
2.2 Chemicals 
Aflatoxin B1 (AB1) and ochratoxin A (OTA) were obtained from Sigma 
Co (St Louis, MO). PBO was purchased from Tokyo Kassie Kogyo (Tokyo, Japan).  
Analytical grade dimethyl sulfoxide (DMSO) was purchased from Fisher Scientific 
(Pittsburgh, PA). All solvents, including DMSO and methanol, were of analytical 
reagent grade. AB1 and OTA were dissolved in DMSO as concentrated stock 
solutions and stored in a –20o C freezer.  
2.3 Substrate carrier 
Chemicals to be tested were administered to bees by incorporation into 
“bee candy,” made using equal weights of powdered sugar and concentrated sugar 
solution with a ratio of 2:1 sucrose to water (w/w). Granulated table sugar (sucrose) 
was ground in a blender for approximately 3 min to make powdered sugar. 
Approximately 5 g fresh candy was poured into a 2 oz (56 ml) plastic cup (Solo, 
Urbana, IL); mycotoxins or a vehicle control were incorporated into the wet candy, 
which was then allowed to harden for 30 min.    
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To test effects of propolis on aflatoxin toxicity to honey bees, propolis 
was collected from hives in a forested area at Phillips Tract Research Area 
(Champaign Co., Illinois). Propolis was frozen in liquid nitrogen and then ground 
with a mortar and pestle and stored at -20o C. Approximately 3 g of ground propolis 
was dissolved in 50 ml of hot methanol. Wax was precipitated from the cooled 
methanol extract and the remaining extract was concentrated to 5 ml by evaporation 
under a stream of air.  Propolis solution was added to powdered sugar and the 
methanol was allowed to dry for 24 h before mixing with an equal mass of heavy 
sugar syrup to make candy with a final concentration of 50, 150 and 300 mg 
propolis/g candy.  
2.4 Bioassays 
Newly eclosed workers were used for bioassays. Stocks of 10 μg/g or 20 
μg/g of AB1 and OTA were dissolved in DMSO and stored at -20o C. Bee candy was 
used to test the oral toxicity of mycotoxins with and without synergists via bioassay. 
For all bioassays, approximately 3 g of unanaesthetized newly emerged bees were 
transferred quickly to a 6 oz (188 ml; Sweetheart, Owings Mills, MD) wax-coated 
paper cup into which the treated candy had been placed. The cups were then covered 
with cheesecloth and placed into a dark humid incubator at a temperature of 32-34o C.  
The mortality of bees was recorded every six hours until all bees had died. 
To determine the oral LC50 of AB1 to bees, AB1 was incorporated into 
candy to achieve levels of 0.5, 1, 2.5, 5, 7, 10, 15 or 20 µg AB1 per g candy; in an 
additional treatment, DMSO was added to bee candy as a control. To determine the 
LC50 of OTA to bees, candy containing 1, 5, 10, 20, 40, 60 or 80 µg/g OTA was 
prepared, along with control candy containing DMSO. To test the effects of the 
known P450 synergist, (PBO, on the toxicity of AB1 or OTA to bees, two 
concentrations of PBO (0.05% or 0.1% PBO) were tested in the presence of AB1 or 
OTA. For AB1 vs PBO bioassays, candy containing six different concentrations of 
chemicals was prepared: 0.1% DMSO, 10 µg/g AB1, 0.05% PBO, 0.1% PBO, 10 
µg/g AB1 supplemented with 0.05% or 0.1% PBO. For the bioassay comparing OTA 
and PBO, two concentrations of OTA (10 and 40 µg/g) were tested and compared 
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with corresponding concentrations of OTA supplemented with 0.05% or 0.1% PBO. 
To determine the effects of propolis, which has been shown to induce a 
subset of P450 enzymes involved in detoxification (Johnson, 2008), the toxicity of 
AB1 and OTA in propolis-treated candy was determined. Five µl of stock AB1 
(20µg/µl) was incorporated into 5g of plain candy to prepare the candy containing 20 
µg/g AB1 or into 5 g of candy containing 50, 150 and 300 mg/g of propolis and 
mixed until the toxin was homogeneously distributed in the fresh candy. Candy 
treated with DMSO only and candy containing 50, 150 or 300 mg/g propolis without 
AB1 were used as controls. 
2.5 Statistics 
The R statistical package (R Development Core Team, 2009) with MASS 
libraries (Venables and Ripley, 2002) was used for log-probit analysis. LC50 values 
with 95% confidence intervals were calculated using Fieller’s method (Finney, 1971). 
Treatments with non-overlapping 95% confidence intervals for LC50 were considered 
significantly different. Survival data to determine effects of PBO or propolis on the 
toxicity of AB1 or OTA to bees were analyzed using SPSS statistical software (SPSS 
Inc., Chicago, IL). With the function of survival analysis in SPSS, the median time 
for survival was calculated for each treatment independently. To compare the data 
among groups in any given bioassay, the data from all treatments were compared 
with one-way analysis of variance (Tukey plot) using the function of survival 
analysis in the software package. In the bioassay testing the effects of PBO on the 
toxicity of AB1 or OTA to honey bees, the p value was calculated to compare effects 
of AB1 or OTA in the presence or absence of the inhibitor. In the bioassay testing the 
effects of propolis extracts on the toxicity of AB1, the p value was calculated to 
compare impacts of AB1 in the presence and absence of propolis. Comparisons 
yielding p values equal to or less than 0.05 were considered to indicate significant 
differences. 
3. Results 
3.1 Toxicity of mycotoxins to A. mellifera 
None of the treatments containing AB1, even at the highest dose of 20 
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μg/g, resulted in bee mortality in less than 24 hours (Fig. 1). The low concentrations 
of AB1 (0.5, 1μg and 2.5μg/g) did not have any apparent toxic effects on bees over 
the entire duration of the bioassays. The intermediate and high doses of AB1 (5μg/g 
and 7μg/g) caused less than 50% mortality after 72 hours. The high doses of AB1 (10, 
15 and 20μg/g) caused over 90% mortality in 72 hours (Fig. 1). The LC50 of AB1 
(defined as the concentration causing 50% mortality of treated bees in 72 hours) was 
6.76 μg/g (95% conf. int.= 5.86-7.69; slope=4.32+/-0.30; Χ2=6.67; df=4; n=590) (Fig. 
3).  
Bees also displayed tolerance of a wide range of concentrations of OTA. 
The low concentration of OTA (1μg/g) did not have any apparent toxicity to bees and 
the treated bees lived as long as did the control bees. As with the AB1 treatments, no 
bee mortality was observed, even at the highest concentrations, in less than 24 hours. 
Over time, mortality increased and concentrations equal to or greater than 10μg/g 
caused 100% mortality after 72 hours. Most of treated bees died during the final 24 
hours (from 48 hours to 72 hours) (Fig. 2). The LC50 of OTA at 72 hours for bees was 
5.04μg/g (95% conf. int.=1.73-7.90; slope=1.11+/-0.28; Χ2=1.49; df=2; n=210) (Fig. 
3).  
While both OTA and AB1 exhibit similar toxicity to bees, the slope of the 
probit lines for AB1 is substantially steeper than is the slope of the probit line for 
OTA, indicating that the response to OTA is more heterogeneous than the response to 
AB1.  
3. 2 Effects of synergists on the toxicity of AB1 or OTA to bees 
Enhancement of the toxicity of AB1 and OTA by administration of PBO, 
a known inhibitor of P450s in bees (Johnson et al., 2008), indicates a role for P450s 
in mycotoxin metabolism in honey bees. Bees started to die earlier when consuming 
candy containing 10μg/g AB1 supplemented either with 0.05% PBO or 0.1% PBO 
than did bees consuming candy supplemented with 10μg/g AB1 alone (Table 1). 
These results suggest that P450s contribute to enzymatic detoxification of AB1 in 
honey bees.  
In contrast with AB1, PBO did not show any synergistic effects on the 
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toxicity of OTA to bees. Two concentrations of PBO (0.05% and 0.1% PBO) were 
applied and two concentrations of OTA (10 and 40μg/g) were used in the bioassays. 
There was no indication that PBO can accelerate or delay death of bees fed OTA 
(Table 1).  
3.3 Effects of propolis on the toxicity of AB1 
To determine whether propolis, as an inducer of P450s, may contribute to 
tolerance of mycotoxins, bioassays of bees fed with AB1 alone or AB1 and propolis 
were conducted. Bees consuming candy containing 20μg/g AB1 started to die after 24 
hours and all had died after 60 hours, whereas bees consuming candy containing the 
same concentration of AB1 supplemented with any amount of propolis lived longer 
than bees fed with AB1 alone; fewer than 10% of bees died in 60 hours (data not 
shown). Survival analysis shows that the median survival time of bees fed with 
20μg/g AB1 is 44 hours while that of bees fed with candy containing 20 μg/g AB1 
plus 50, 150 or 300 mg/g propolis is 126, 150 and 154 hours, respectively. There is a 
significant difference in survival time between bees treated with AB1 and those 
treated with AB1 and propolis (Table 2). Longer median survival time with higher 
concentrations of propolis (150 mg/g and 300 mg/g) suggests a dosage-dependent 
ameliorative effect of propolis on AB1 toxicity. 
4. Discussion  
As repositories of large quantities of food resources maintained under 
conditions of high relative humidities and temperatures, beehives are particularly 
vulnerable to opportunistic fungal infections. Given the frequency with which fungi 
such as Aspergillus colonize such environments, the relative tolerance that A. 
mellifera displays to mycotoxins such as AB1 and OTA is ecologically consistent 
with the likelihood of exposure. Similarly, H. zea, the corn earworm, which only 
intermittently encounters aflatoxins in its preferred foodplants, displays substantially 
greater sensitivity to AB1 than does A. transitella, the navel orangeworm, which 
routinely (and possibly preferentially) consumes fungus-contaminated plant food.   
How A. mellifera tolerates mycotoxins such as aflatoxins and ochratoxins 
has not yet been determined definitively. In aflatoxin-tolerant species such as H. zea 
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and A. transitella, metabolism of AB1 to non-toxic products is mediated by P450s 
(Niu et al., 2008); in species that are less tolerant, such as Drosophila melanogaster, 
P450-mediated metabolism appears to result in epoxidation and hence bioactivation, 
or enhanced toxicity (Saner et al., 1995). That administration of PBO in the presence 
of aflatoxin increased toxicity suggests that the honey bee, like the aflatoxin-tolerant 
H. zea and A. transitella, transforms these compounds to nontoxic metabolites via 
P450-mediated metabolism. Recent work by Johnson et al. (2009) indicates that the 
organophosphate coumaphos is also metabolized via P450s in bees to nontoxic 
products, rather than bioactivated to the more toxic oxon metabolite, as is the case for 
most insects. 
Ochratoxins are also produced by fungi that can be found in hive products 
(Gilliam et al., 1989). We found that, although workers can tolerate low levels of 
OTA (1 µg/g), concentrations higher than 5 µg/g will kill over 50% of exposed bees 
in 3 days under bioassay conditions. To date, no studies have been published on OTA 
metabolism by insects. Although metabolism of OTA in mammals is mediated 
primarily by P450s (Neal, 1995), the fact that, in our study, PBO has no effects on 
OTA toxicity suggests that this enzyme system might not be involved in the 
detoxification of OTA in honey bees. Studies with synergists must be interpreted 
cautiously, however, inasmuch as PBO does not necessarily inhibit all P450-mediated 
transformations in insects (Sanchez-Arroyo et al., 2001).    
Propolis, prepared from resinous materials collected from plants by honey 
bees, is thought to function principally as a sealant for gaps within the hive to 
enhance structural stability (Burdock, 1998; Bankova, 2005). It also plays a key role 
in reducing decay of extraneous organic material within the hive and may also help 
bees fend off parasites and pathogens. Its antimicrobial activity is attributed to its 
high content of flavonoids and phenolics and in fact propolis extracts in vitro can 
inhibit the growth of fungi, including Aspergillus versicolor, A. flavus, A. sulphureus 
and A. parasiticus, and suppress production of mycotoxins, including AB1, OTA and 
sterigmatocystin (Aly and Elewa, 2007; Gómez-Caravaca et al., 2006; Ozcan 2004; 
Pepeljnjak et al. 1982; Viuda-Martos et al., 2008). Simone et al. (2009) recently 
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showed that exposure to propolis extracts downregulates expression of two honey bee 
immune-function genes concomitant with lowering the eubacterial loads, suggesting 
that propolis in the hive may reduce the need for immune gene expression by 
reducing bacterial loads.  
That propolis may contribute to honey bee defense against fungi and their 
associated toxins not only by suppressing microbe growth but also by enhancing 
detoxification enzymes is a novel hypothesis consistent with the results of our study, 
at least with respect to AB1. Of the 46 P450s that are found in the honey bee genome, 
several in the CYP6AS subfamily are selectively induced by hive products such as 
honey, pollen and propolis, indicating a possible role in xenobiotic detoxification 
(Johnson, 2008); indeed, Mao et al. (2009) demonstrated that CYP6AS3 is capable of 
metabolically transforming quercetin, a flavonoid found in propolis and in a wide 
variety of honeys. The ability of propolis to ameliorate the toxicity of AB1, as 
demonstrated in this study, suggests a function for propolis as an adjuvant for 
detoxification. Although the honey bee genome contains far fewer P450 genes than 
do other sequenced insect genomes, bees may compensate for reduced numbers by 
efficiently regulating the expression of a small number of P450s for detoxification by 
induction with dietary phytochemicals. Individual P450s might be greatly induced by 
propolis extracts to bio-transform AB1 into less toxic compounds, thereby reducing 
the risks of exposure to mycotoxins.  
Propolis has long been used in traditional medicine and has been credited 
with immuno-modulatory, anti-inflammatory and antimicrobial activity. At least some 
of the therapeutic activity of propolis in alternative medicine has been attributed to its 
function as an inducer of P450 activity (Bhaudauria et al., 2007). Propolis treatment 
has been shown to increase activities of a range of P450s, including pentoxyresorufin 
depentylase, and ethoxycoumarin deethylase (Siess et al. 1996). More recently, 
Beltrán-Ramírez et al. (2008) reported that caffeic acid phenethyl ester, a common 
constituent of propolis, can modify expression of multiple P450s to inhibit the 
activation of diethylnitrosamine in rats. To some extent, it is remarkable that the body 
of knowledge relating to the biochemical activity of propolis in human health is 
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substantially larger than that relating to the biochemical activity of propolis in honey 
bee health; a greater understanding of the multiple roles of propolis in the life of the 
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Table 1. Survival analysis of effects of piperonyl butoxide (PBO) on toxicity of 
AB1 or OTA to bees. Bioassays were conducted to compare survival time of groups 
of bees fed mycotoxins in the presence and absence of PBO. Estimated median for 
survival time of bees fed “candy” containing10 µg/g AB1, 10 µg/g or 40 µg/g OTA, 
0.05% PBO, 0.1% PBO, 10 µg/g AB1 supplemented with 0.05% PBO or 0.1% PBO, 
10 µg/g or 40 µg/g OTA supplemented with 0.05% PBO or 0.1% PBO is the average 
of three replicates. Treatments of PBO plus toxin that differ significantly from toxin 
alone are indicated with “*” (p < 0.05). 
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Table 2. Survival analysis of effects of propolis on toxicity of aflatoxin B1 (AB1) 
to bees. Bioassays were conducted to compare survival time of groups of bees fed 
mycotoxins in the presence of different concentrations of propolis. Estimated median 
survival time of bees fed “candy” containing 20 µg/g AB1, 50 mg/g, 150 mg/g and 
300 mg/g propolis, and 20 µg/g AB1 supplemented with either of 50 mg/g, 150 mg/g 
or 300 mg/g propolis is the average of three replicates. Survival times for groups 
feeding on propolis and AB1 that are significantly different from survival time of 












 Fig. 1 Mortality of Apis mellifera exposed to different concentrations of dietary 
aflatoxin B1 (AB1). Groups of approximately 30 newly enclosed workers were 
tested with “bee candy” containing a range of concentrations of AB1 in DMSO and 
candy containing DMSO only. Each experiment was repeated three times; this figure 








Fig. 2 Mortality of Apis mellifera exposed to different concentrations of dietary 
ochratoxin A (OTA). Groups of approximately 30 newly enclosed workers were 
exposed to “bee candy” containing a range of concentrations of OTA in DMSO and 
control containing DMSO only. . Each experiment was repeated three times; this 






Fig. 3 Comparison of LC50 of AB1 and OTA to bees.  Plots of probits of bee 
mortality relative to different concentrations of AB1 or OTA. A (red) depicts AB1 
treatments; O (black) depicts OTA treatments. LC50 is defined as the concentration of 
toxin that can cause 50% mortality of the tested bees after 72 hours. Each experiment 
was repeated three times and the estimated LC50 is the average of three replicates. 




















IV Aflatoxin B1 detoxification by CYP321A1 in Helicoverpa zea 
Abstract 
 The polyphagous corn earworm Helicoverpa zea frequently encounters 
aflatoxins, mycotoxins produced by the pathogens Aspergillus flavus and A. 
parasiticus, which infect many of this herbivore’s hostplants. While aflatoxin B1 
metabolism by midgut enzymes isolated from fifth instars feeding on control diets 
was not detected, this compound was metabolized by midgut enzymes isolated from 
larvae consuming diets supplemented with xanthotoxin, coumarin, or 
indole-3-carbinol, phytochemicals that are likely to co-occur with aflatoxin in 
infected hostplants. Of the two metabolites generated, the main derivative identified 
in midguts induced with these chemicals and in reactions containing heterologously 
expressed CYP321A1 was aflatoxin P1 (AFP1), an O-demethylated product of AFB1. 
RT-PCR gel blots indicated that the magnitude of CYP321A1 transcript induction by 
these chemicals is associated with the magnitude of increase in the metabolic 
activities of induced midgut enzymes (coumarin>xanthotoxin>indole 3-carbinol). 
These results indicate that induction of P450s, such as CYP321A1, plays an 
important role in reducing AFB1 toxicity to H. zea. Docking of AFB1 in the 
molecular models of CYP321A1 and CYP6B8 highlights differences in their 












1. Introduction        
         Cytochrome P450 monooxygenases (P450s) comprise a large superfamily of 
hemoproteins that contribute to detoxification in virtually all aerobic organisms, 
including insects (Feyereisen, 2005). Within every genome, the multiplicity of P450s 
with potentially broad substrate specificity presents a challenge with respect to 
identifying ecologically relevant substrates. While some P450-mediated reactions 
convert chemical(s) to more toxic substances, many more mediate the detoxification of 
toxic chemical(s) into less toxic metabolites. Depending on the proportions of each 
type of P450 expressed in a particular tissue or developmental stage, compounds can 
either be bioactivated or detoxified (McLean and Dutton, 1995; Neal, 1995; 
Guengerich, 2006). In some cases, as in the vertebrate P450-mediated metabolism of 
aflatoxin B1, a fungal toxin produced by Aspergillus flavus and Aspergillus parasiticus, 
a single compound can be both detoxified and bioactivated by a single P450 (Gallagher 
et al., 1996; Johnson et al., 1997; Guengerich et al., 1998).  
          Characterizing ecologically significant P450 substrates is also complicated 
by the fact that expression of individual P450 genes can be up- or down-regulated by 
different compounds ingested by the organism. For herbivorous insects, regulation of 
P450 expression by phytochemicals and other dietary constituents is of particular 
importance in that herbivores encounter these compounds in a variety of combinations, 
depending on the nature of the plant tissue ingested (Zeng et al., 2007). The ecological 
consequences of such phytochemical regulation depend on the P450s involved and the 
toxins encountered by herbivores subsequent to phytochemical exposure: 
up-regulation of detoxicative processes is likely to be beneficial to the herbivore 
whereas down-regulation of detoxification and up-regulation of bioactivation are 
likely to be detrimental to the herbivore. 
Among the dietary constituents whose metabolism may be affected by 
co-occurring phytochemicals are mycotoxins produced by plant pathogens. 
Contamination of crops by aflatoxins causes losses of millions of dollars annually in 
the United States primarily because their toxic effects make contaminated grains 
unsuitable for livestock and human consumption (Robens and Cardwell, 2005). 
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Studies in vertebrate systems have indicated that the toxicity of AFB1 is derived from 
its conversion by P450s and lipoxygenases to AFB1-8,9-exo-epoxide (AFBO), a 
highly reactive compound that interacts with DNA to form guanyl N7-adducts 
capable of inhibiting DNA synthesis and generating point mutants that activate 
protooncogenes, inactivate cancer suppressor genes, and/or alter protein functions 
(Eaton and Gallagher, 1994; McLean and Dutton, 1995; Guengerich et al., 1998). In 
these systems, detoxification of AFB1 is achieved by several P450-mediated routes, 
including the formation of hydroxylated metabolites such as AFM1, AFQ1, AFB2a 
and AFP1, which have lower or no ability to form the 8,9-exo-epoxide (AFBO). 
AFB1 can also be directly reduced to aflatoxicol (AFL) by NADPH-dependent 
reductases but this derivative is rapidly converted back to AFB1 by a dehydrogenase 
(Eaton and Gallagher, 1994). The highly mutagenic AFBO formed in some vertebrate 
systems (but not any known insect systems) can be detoxified by glutathione 
S-transferase (GST)-mediated conjugation with glutathione (GSH) and, often, the 
sensitivity of different mammalian species to AFB1 is associated with the activities of 
their GSTs (Wong and Hsieh, 1980; Degen and Neumann, 1981; Lotlikar et al., 
1984).  
Aspergillus infections of crops, with concomitant aflatoxin contamination, 
are often exacerbated by infestations of insects such as Helicoverpa zea (Dowd and 
White, 2002), a broadly polyphagous species associated with a wide range of crop 
species (Neunzig et al., 1963; Archer and Bynum, 1994; Capinera, 2001). In contrast 
with vertebrates, little is known about AFB1 biotransformations in insects. While no 
direct in vitro or in vivo evidence exists for the transformation of AFB1 to AFBO in 
insects, several studies have indirectly suggested that insect P450s bioactivate AFB1. 
In particular, Saner et al. (1996) demonstrated that Drosophila melanogaster 
CYP6A2 is capable of transforming AFB1 into a product that induces gene 
conversion. Zeng et al. (2006) demonstrated that addition of a P450 inhibitor, 
piperonyl butoxide (PBO), to H. zea diets containing 1 µg/g AFB1 significantly 
decreases the toxicity of AFB1 to fourth instars and increases the pupation rate 
compared to that of larvae on diets containing only AFB1. In contrast with this 
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apparent bioactivation of AFB1, several detoxified metabolites, including AFM1, 
AFB2a and AFL, have been identified in in vitro metabolism experiments conducted 
with D. melanogaster, Amyelois transitella (navel orangeworm) and Cydia 
pomonella (codling moth) (Foerster and Wurgler, 1984; Lee and Campbell, 2000).  
Li et al. (2002a,b) and Zeng et al. (2007) have shown that defenses against 
naturally occurring and synthetic xenobiotics can be dramatically enhanced in H. zea 
following ingestion of certain phytochemicals. Relevant to this study, a variety of 
plant phytochemicals, including xanthotoxin, coumarin, and indole-3-carbinol, 
significantly reduced the toxicity of AFB1 to H. zea, as evidenced by increased 
pupation rates and pupal weights. Molecular analyses have indicated that several 
members of the H. zea CYP6B subfamily (CYP6B8, CYP6B27, CYP6B28) and 
CYP321A1 are differentially regulated by these compounds (Li et al., 2002a,b, 2004; 
Sasabe et al., 2004; Zeng et al., 2007). With CYP6B8 and CYP321A1 known to 
metabolize an array of phytochemicals and insecticides (Li et al., 2002a,b, 2004; 
Sasabe et al., 2004; Rupasinghe et al., 2007), we examined the mode of AFB1 
detoxification induced by phytochemicals in this species. Our results indicate that at 
least one P450 up-regulated 8- to 20-fold by these chemicals, CYP321A1, 
metabolizes AFB1 into two products, with the major product corresponding to the 
less toxic AFP1.  
2. Materials and Methods 
2.1 Chemicals and biological materials 
The aflatoxin standards (AFB1, AFB2, AFM1, AFG1, AFG2), plant 
allelochemicals (indole-3-carbinol, coumarin, xanthotoxin) were purchased from 
Sigma Chemical Co. (St. Louis, MO). Analytical grade dimethyl sulfoxide (DMSO) 
and piperonyl butoxide (PBO) were purchased from Fisher Scientific (Hampton, NH). 
All of these compounds were dissolved in DMSO as stocks stored in –20°C. A 
laboratory strain of H. zea provided by Abbott Laboratories (Chicago, IL) was 
maintained in an insectary kept at 23-26°C with a photoperiod of 16 hr light: 8 hr 
dark. H. zea larvae were individually reared in 30 ml creamer containers on a 
semisynthetic diet containing wheat germ (Waldbauer et al., 1984). Mouse livers 
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were provided by Renhao Lai and Dr. Elizabeth Jeffery (UIUC) and purified rat liver 
glutathione-S-transferase proteins were obtained from Sigma Chemical (St. Louis, 
MO). Mice were anesthetized by using CO2, followed by cervical dislocation. Livers 
were collected immediately and frozen on dry ice and stored at -80°C until use. All 
mouse procedures were approved by the UIUC Animal Care and Use Committee and 
were conducted in accordance with its policies. 
2.2 Preparation of insect and mouse microsomal and cytosolic fractions 
A group of 20 fifth instars that had all molted within the same 12 hr period 
were fed with artificial diets containing 0.2% DMSO (control), 1 mg/g indole 
3-carbinol, 1 mg/g coumarin, 0.5 mg/g xanthotoxin, 1 µg/g AFB1 for 48 hr. Midguts 
were then dissected in ice-cold 0.1 M phosphate buffer (pH 7.8) and stored at -80 ºC. 
The frozen midguts were ground to a fine powder using mortars and pestles in the 
presence of liquid N2. Each powdered midgut sample derived from 20 larvae was 
then transferred into a 2 ml glass homogenizer containing 1.5 ml resuspension buffer 
(0.1 M phosphate buffer (pH 7.8), 1 mM EDTA, 0.5 mM PMSF, 0.1 mM DTT, 20% 
glycerol) and ground for 10 strokes. Each homogenate was transferred to a 2 ml 
Eppendorf tube and centrifuged at 10,000x g at 4ºC for 10 min and the supernatant 
was reserved as the crude protein and stored at -80oC.  
For preparation of mouse microsomal and cytosolic samples, to generate 
known metabolites for comparison, circa 1 g of mouse liver was homogenized in a 15 
ml glass homogenizer containing 5 ml 0.1M ice-cold phosphate buffer (pH 7.4). The 
homogenates were filtered with four layers of cheesecloth and then spin at 10,000x g 
at 4ºC for 10 min. The supernatant fraction was centrifuged at 100,000x g at 4ºC for 1 
hr to pellet liver microsomes and the resultant cytosolic supernatant was frozen in 
liquid nitrogen and stored at -80 ºC. 
2.3 Expression of insect P450s  
Heterologous expression of H. zea P450s in Sf9 cells was carried out as 
described in Wen et al. (2003) and Sasabe et al. (2004) with minor modifications. The 
CYP321A1, CYP6B27 and CYP6B8 recombinant viruses were coexpressed with 
house fly P450 reductase recombinant virus at MOI (multiplicity of infection) ratios 
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of 2:2, 1:1 and 1:1, respectively, for 72 hr at 28oC. At the end of this incubation, 20 
ml infected cells were pelleted by centrifugation at 5,000 rpm for 10 min and the cell 
pellets were washed once with an equal volume of 0.1 M phosphate buffer (pH 7.8) 
and resuspended in one-tenth volume cell lysis buffer (0.1 M phosphate buffer (pH 
7.8), 1 mM EDTA, 0.5 mM PMSF, 0.1 mM DTT, 20% glycerol), sonicated two times 
for 30 sec (for 5 ml resuspended cells with a 30 sec rest between sonications). The 
sonicated cell lysates were cleared by centrifuging at 10,000 rpm for 10 min and the 
final supernatants were stored at -80oC. The P450 content of each sample was 
determined by CO difference analysis (Omura and Sato, 1964).  
2.4 In vitro metabolism of AFB1  
AFB1 metabolism assays conducted with midgut proteins were adapted from 
Lee and Campbell (2000) by extending reaction times to 3 hr, decreasing the 
temperature to 30oC and changing the pH of the phosphate buffer to 7.8. More 
specifically, each 250 µl reaction consisted of 2 mg/g tested crude protein 
[approximately 50 µl 10 mg/ml crude extract added in the reaction with the final 
concentration of 2 mg/ml], 0.1 mM phosphate buffer (pH 7.8), 0.5 mM NADPH, 0.5 
mM GSH and 128 µM AFB1. The reactions were pre-incubated for 10 min at room 
temperature and initiated by addition of NADPH and GSH. After incubation at 30oC 
for 3 hr, the reactions were stopped by adding 1 ml cold methanol containing 10 µM 
AFG1 (as an internal control). The reaction mixtures were then centrifuged at 
12,000x g for 10 min at room temperature and the supernatants were filtered on 
micro spin-down filter columns (Alltech, Deerfield, IL) before injection into the 
HPLC. Metabolites of AFB1 were analyzed by reverse-phase HPLC on a Supercosil 
LC-18 column (250 mm x 4.6 mm) equipped with a photodiode array UV detector 
using as mobile phase a mixture of water/methanol/acetonitrile (60/20/20) at a flow 
rate of 1 ml/min. In this system, the retention times for different standards were 
AFB1 (14 min), AFB2 (12.3 min), AFG1 (10.7 min), AFG2 (9.0 min) and AFM1 (7.5 
min). AFB1 metabolites were identified by LC-MS analysis and comparison of their 
retention times with those of standards by HPLC chromatography. Due to limitations 
60 
in the number of larvae in our insect colony, we were unable to calculate steady-state 
kinetics for AFB1 metabolism in midgut homogenates. 
AFB1 metabolism assays with P450s expressed in insect cells were set up as 
for midgut homogenates using varying amounts of sonicated Sf9 cell lysates 
containing 10 pmol CYP321A1, 25 pmol CYP6B8 or 25 pmol CYP6B27. The 
activities of CYP6B8, CYP6B27 and CYP321A1 were determined at final 
concentrations of 26 μM, 51 µM, 102 µM, 128 µM and 192 µM AFB1 in reactions 
terminated at 90 min with assays replicated three times for each independent 
biological sample. The disappearance rates of AFB1 by CYP321A1 in the reactions 
containing varying concentrations of AFB1 were calculated on the basis of substrate 
disappearance. Plots of AFB1 disappearance (Vs) relative to substrate concentration 
and the kinetic parameters (Vmax, Km) were made using Graphpad Prism version 
3.03 software (Graphpad Software Inc., San Diego, CA).  
PBO inhibition assays were conducted as above except that 1 mM PBO 
dissolved in N, N-dimethylformamide was added to reactions and these were 
compared to reactions containing an equal volume of N-dimethylformamide but 
lacking NADPH. Because there were no detectable metabolites using proteins 
isolated from control insects, crude proteins isolated from midguts of H. zea treated 
with coumarin or xanthotoxin were used for PBO inhibition studies.  
2.5 Detection of AFBO conjugates  
To trap AFBO conjugates, mouse liver cytosol (10 µl 50 mg/ml) or 
purified rat liver GSTs (50 µl/mg/ml) were added into the 250 µl reactions containing 
crude protein from H. zea midguts of larvae treated with coumarin or Sf9 cell lysates 
expressing CYP321A1. Reactions were stopped after incubation at 30oC for 3 hr and 
10 µl of filtered supernatant were injected for HPLC analysis.  
2.6 LC-MS Analysis 
AFB1 metabolites were collected from 20 metabolism reactions 
containing crude protein of H. zea induced with coumarin or 2 reactions conducted 
with 0.01 nmoles of heterologously expressed CYP321A1 protein. These metabolites 
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were vacuum-dried to a final volume of 0.5 ml and 50 µl of concentrated metabolites 
were collected for LC-MS analysis. LC/MS analysis was performed using the LCQ 
Deca XP electrospray ionization mass spectrometer equipped with a MS pump, 
autosampler and photodiode array detector (Thermo Fisher Scientific, Waltham MA). 
2.7 RT-PCR Southern analysis  
RNA was isolated from the homogenized midguts using TRIzol reagent 
(Gibco-BRL). One-step RT-PCR reactions were set up as described in Li et al. (2002b) 
with each 50 µl reaction including 100 ng RNA, 1x RT-PCR buffer, 20 U RNasin 
(Promega, Madison, WI), 5 U AMV reverse transcriptase (Promega), 10 pmoles each 
forward and reverse primer and 1.25 U Taq polymerase (Invitrogen, Carlsbad, CA). 
The gene-specific forward/reverse primer sets used for CYP321A1 in these reactions 
corresponded to 5'-TAGTGTGGAGGGTGACCAACTG-3'/5'- 
CGGACAACAAGCCAGTCGTAGGC-3'. First stage RT reactions were incubated at 
42ºC for 50 min and second stage PCR reactions proceeded with 18 cycles with each 
conducted at 94ºC for 1 min, 60ºC for 1 min and 72ºC for 1 min. Ten µl of each 
RT-PCR reaction were analyzed on 1% agarose-1x TBE gels and the RT-PCR 
products were transferred to Hybond-N membranes (Amersham-Pharmacia 
Biosciences, Uppsala) and hybridized with a 32P-labeled purified PCR fragment of the 
CYP321A1 cDNA at 42ºC in 5x SSC, 5x Denhardt’s solution, 50% formamide, 50 
mM sodium phosphate (pH 7.0) and 0.5% SDS. Membranes were washed twice for 15 
min in low stringency buffer (2x SSC, 0.1% SDS) at 42ºC, twice for 15 min at high 
stringency buffer (0.2x SSC, 0.1% SDS) at 62ºC and quantified by Phosphorimager 
(Amersham-Pharmacia Biotech) analysis. RT-PCR Southern analyses were repeated at 
least two times with RNA samples prepared from midguts of larvae in two independent 
biological replicates. 
2.8 Statistical analyses 
All enzymatic reactions were repeated at least twice and the means of the 
replicates in different groups were compared and tested for significant differences 
from controls using the Tukey post-hoc test at P=0.05 with SAS software.  
2.9 Docking of AFB1 in the CYP321A1 model 
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Development of the CYP321A1 and CYP6B8 models is discussed in detail 
in Rupasinghe et al. (2007). Briefly, seven eukaryotic or eukaryotic-like P450 crystal 
structures (CYP3A4 (1TQN) (Yano et al., 2004), CYP2C8 (1PQ2) (Schoch et al., 
2004), CYP2B4 (1SUO) (Scott et al., 2004), CYP2C5 (1N6B) (Wester et al., 2003), 
CYP2C9 (1OG5) (Williams et al., 2003), CYP102 (2HPD) (Ravichandran et al., 
1993), CYP2A6 (1Z1O) (Yano et al., 2005)) and one bacterial P450 crystal structure 
(CYP175A1 (1N97) (Yano et al., 2003)) were aligned using the ALIGN facility in 
MOE (Molecular Operating Environment) versions 2004 and 2005 (Chemical 
Computing Group Inc., Montreal, Canada) that uses the BLOSUM62 scoring matrix. 
The CYP6B8 and CYP321A1 sequences were then aligned to this fixed alignment 
and ten models were generated for each target sequence using the CYP3A4 crystal 
structure as the primary backbone template and coordinates from the CYP2B4 crystal 
structure for the highly divergent B’ helix B-C loop region and F-G loop region as 
detailed in Baudry et al. (2006). Docking of the AFB1 ligand was performed using 
LigandFit implemented in the program Cerius2 (Version 4.10. Accelrys, San Diego, 
USA). For this substrate, 100 possible conformations were generated and ranked 
according to dock score provided in LigandFit. The binding conformation for each 
protein with the highest score (lowest interaction energy) was selected as the optimal 
conformation and subjected to further energy minimization using the MMFF94 force 
field in MOE; heme coordinates were fixed to prevent distortion of the heme plane 
originating from bonded parameters in the MOE’s implementation of the MMFF94 
force field.  
3. Results 
3.1 In vitro metabolism of AFB1 by H. zea midgut proteins 
To determine the effect of plant allelochemicals on AFB1 metabolism, we 
compared AFB1 metabolism by H. zea using midgut proteins isolated from larvae fed 
on control diets and diets supplemented with plant allelochemicals (coumarin, 
xanthotoxin or indole 3-carbinol). While no metabolites were detected when AFB1 
was incubated with midgut proteins isolated from larvae feeding on the control diet 
(Fig. 1A), the same two polar metabolites (Met1 with retention time of 7.0 min and 
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Met2 with retention time of 7.4 min) were readily detected when AFB1 (retention 
time of 14.0 min) was incubated with midgut proteins isolated from insects 
consuming diets containing coumarin or xanthotoxin (Fig. 1B and data not shown). 
Only trace amounts of a metabolite with the same retention time as Met1 were 
detected when AFB1 was incubated with midgut proteins isolated from insects 
consuming diets containing indole 3-carbinol (data not shown).  
In in vitro reactions using midgut proteins isolated from insects feeding on 
diets containing coumarin, production of the Met1 and Met2 metabolites required 
NADPH and was completely inhibited by PBO (piperonyl butoxide), a general P450 
inhibitor, indicating that these derivatives were produced by P450s. LC-MS analyses 
of the AFB1 metabolites generated using midgut proteins isolated from 
coumarin-treated larvae indicate that Met1 has a molecular weight of 298, which is 
consistent with O-demethylation of AFB1 to produce AFP1 (Fig. 2), a hydroxylated 
metabolite of AFB1 by vertebrates which has been demonstrated to be less toxic than 
AFB1 (Stoloff et al., 1972; Eaton and Gallagher, 1994). Because it was recovered in 
such small quantities, we were unable to determine the molecular weight of Met2 
using LC-MS analyses, but co-injection experiments conducted with aflatoxin M1 
(AFM1, retention time 7.5 min) convincingly demonstrated that Met2 (7.4 min) is not 
this hydroxylated product.  
Further analysis determined the turnover rates of AFB1 in reactions 
containing midgut proteins at a concentration of 2 mg/ml incubated at 30oC for up to 
3 hr. Under these conditions, the metabolites formed in reactions using midgut 
proteins isolated from coumarin-treated larvae increased linearly with time for at 
least 3 hr. Because commercial AFP1 was not available, AFB1 metabolism was 
evaluated both by the relative disappearance rate of the AFB1 parent compound as 
well as by the increased production of metabolites defined as the integrated 
metabolite areas divided by the integrated AFG1 (internal standard) area. As shown 
in Table 1, among all of the chemicals tested, coumarin is the most significant 
inducer of AFB1 metabolism in corn earworm with the disappearance rate for AFB1 
being 51.4 pmol/min/mg protein and the appearance rates for Met1 and Met2 being 
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equivalent to 17.1% and 6.1% of the AFG1 standard, respectively. 
Xanthotoxin-induced midgut proteins also generated the same Met1 and Met2 
metabolites but at significantly lower rates; in these samples, AFB1 disappearance 
was 27.0 pmol/min/mg protein and Met1 and Met2 production were nearly equivalent 
(10.9% and 9.4% of the AFG1 standard, respectively). The fact that the relative 
proportion of these metabolites differ in coumarin- and xanthotoxin-induced midgut 
samples indicates that more than one enzyme is involved in AFB1 metabolism in H. 
zea midguts 
3.2 In vitro metabolism of AFB1 by CYP321A1  
To determine whether any of the known H. zea P450s are capable of 
metabolizing AFB1, CYP6B8 (Li et al., 2000), CYP6B27 (Li et al., 2002c) and 
CYP321A1 (Sasabe et al., 2004) were coexpressed with house fly P450 reductase 
using baculovirus expression systems as described in Wen et al. (2003) and Sasabe et 
al. (2004). Varying MOI ratios of recombinant P450 and P450 reductase viruses were 
tested to optimize activity of these P450s toward their common xanthotoxin substrate. 
After these optimizations, comparisons of the metabolic activities of CYP6B8, 
CYP6B27 and CYP321A1 toward AFB1 were conducted with cell lysates prepared 
from Sf9 cells coexpressing these proteins at MOI ratios of 1:1, 1:1 and 2:2 (P450: 
P450 reductase), respectively. No parent compound disappearance or metabolite 
formation was detected when AFB1 was incubated with either CYP6B8 or CYP6B27. 
In contrast, two metabolites with exactly the same retention time as Met1 and Met2 
(Fig. 1) were detected when AFB1 was incubated with CYP321A1, suggesting that 
the AFB1 metabolites produced by CYP321A1 are the same as those formed by the 
corn earworm midgut proteins. The ratio of Met1 to Met2 generated in the reaction is 
around 1.8:1, which is lower than that obtained with midgut proteins of larvae 
induced with coumarin (2.8:1) and higher than that obtained with midgut proteins of 
the larvae induced with xanthotoxin (1.2:1) (Table 1). The AFB1 disappearance rate 
calculated in nmol AFB1/min/nmol P450 displays Michaelis-Menten kinetics (Fig. 3). 
Nonlinear regression analysis reveals that CYP321A1 metabolizes AFB1 with Vmax 
and Km values of 3.9 nmol AFB1 metabolized/min/nmol P450 and 241 µM, 
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respectively.  
3.3 Absence of AFBO-GSH conjugates 
 Given that AFB1 appears to be bioactivated into the more toxic AFBO, we 
determined whether H. zea larvae fed on diets containing coumarin were capable of 
converting AFB1 to AFBO. In vitro reactions conducted with midgut proteins 
induced with either of these treatments generated no detectable AFBO-conjugates 
even when mouse liver cytosol or purified rat liver glutathione S-transferases, which 
are both AFBO trapping agents, were added (data not shown). 
3.4 Induction of CYP321A1 transcripts 
 The fact that H. zea larvae consuming control diets did not metabolize AFB1 
at detectable levels and that both heterologously expressed CYP321A1 protein and 
midgut proteins isolated from larvae fed on phytochemical-containing diets generated 
the same two metabolites suggested that these phytochemicals might induce the 
CYP321A1 locus. Semi-quantitative RT-PCR gel blot analyses performed with RNA 
isolated from fifth instars fed for 48 hr on diets containing these phytochemicals (Fig. 
4) indicate that all three plant allelochemicals tested (xanthotoxin, coumarin, 
indole-3-carbinol) are capable of inducing CYP321A1 transcripts compared with 
their low basal level in DMSO-treated control larvae. The magnitude of induction by 
these three phytochemicals corresponds to coumarin (42-fold), xanthotoxin (24-fold) 
and indole-3-carbinol (7-fold). This pattern of transcript inducibility at the CYP321A1 
locus is consistent with the AFB1 metabolism profiles by midgut proteins isolated 
from larvae ingesting these phytochemicals: compounds failing to induce CYP321A1 
also fail to induce AFB1 metabolism in the midguts of H. zea exposed to plant 
allelochemicals, and compounds inducing higher levels of CYP321A1 transcripts 
also induce higher levels of AFB1 metabolism in H. zea midguts.  
3.5 Docking of AFB1 in the CYP321A1 model  
To understand the binding modes for AFB1 in the predicted CYP321A1 
and CYP6B8 catalytic sites, this CYP321A1 substrate was computationally docked in 
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both catalytic sites using the Monte-Carlo docking procedures within MOE and 
repeated cycles of protein and substrate minimization. Of 100 different conformations 
checked for this substrate in these two P450 sites, the lowest energy binding mode for 
each protein was subjected to further energy minimizations with all side chains fully 
relaxed. Examinations of the fully minimized AFB1 binding modes predict that it 
binds in the CYP321A1 catalytic site with the 8-methoxy group at a distance of 3.23 
Å from the oxygen of the iron-oxo intermediate (Fig. 5) and in the CYP6B8v1 
catalytic site at a distance of 7.63 Å. In these binding modes, AFB1 is predicted to 
have lower interaction energies for CYP321A1 (-50.0 kcal/mol) than for CYP6B8 
(-41.0 kcal/mol). Among the side chains within AFB1 contact distance (<4.5 Å) 
shown in Fig. 5, several stand out as being remarkably conserved in these highly 
divergent P450s (aqua residues R104/R104 in SRS1, A305/A303 and E308/E306 in 
SRS4; each of these pairs is numbered with respect to CYP6B8/CYP321A1). Others 
are highly variable (elemental residues in Fig. 5) with some, such as F118/T119 and 
Q375/T373, contributing significantly to reducing the volume of the CYP6B8 
catalytic site closest to the heme (180 Å3) compared to this same region in the 
CYP321A1 catalytic site (325 Å3). As a result, the methoxy group on AFB1 is 
predicted to dock substantially closer to the heme in the CYP321A1 model than to 
any region in the CYP6B8 model.  
4. Discussion 
Because metabolites of AFB1 were not detected in assays conducted with H. 
zea midgut proteins, it appears that this herbivore is not an efficient metabolizer of 
AFB1 or that it produces metabolites that are unstable. That AFB1 is more efficiently 
metabolized after exposure to plant allelochemicals is consistent with our previous 
finding that this polyphagous species is able to enhance its resistance to plant toxins 
and insecticides by increasing its P450-mediated metabolic capacities in response to 
certain allelochemicals (Li et al., 2000, 2002a, 2004; Sasabe et al., 2004). The further 
demonstration that CYP321A1 detoxifies AFB1 to the same two metabolites (AFP1 
(Met1), Met2) generated by coumarin- and xanthotoxin-induced midgut proteins has 
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identified one significant allelochemical-inducible P450 responsible for protection 
against this fungal toxin. For CYP321A1, which shares many of the same catalytic 
activities as CYP6B8 (Sasabe et al., 2004; Rupasinghe et al., 2007), this represents a 
major innovation that can allow this insect to survive on food sources contaminated 
with Aspergillus flavus and A. parasiticus.  
Inasmuch as the herbivorous H. zea likely never encounters mycotoxins in 
the absence of plant tissue, induction of AFB1 metabolism by co-occurring 
phytochemicals is consistent with the feeding ecology of this species. In vertebrates, 
multiple mechanisms are involved in phytochemical-induced chemoprotection against 
aflatoxins and related mycotoxins, including induction of phase I and phase II 
detoxification enzymes (P450s, GSTs, reductases) as well as the inhibition of P450s 
bioactivating aflatoxins (Kensler, 1997). Any one of the phytochemicals tested here 
may have multiple functions in H. zea as well: indole-3-carbinol is known to be 
capable of inducing rat P450s that activate AFB1 (CYP1A1, CYP1A2, CYP3A1, 
CYP3A2) as well as enzymes that detoxify AFB1 (aflatoxin B1-aldehyde reductase, 
glutathione S-transferase, NADPH:quinone oxidoreductase). The extent of 
chemoprotection in this vertebrate is determined by the balance attained between these 
bioactivation and detoxification processes (Stresser et al., 1994; Manson et al., 1998). 
Similarly, reduction of AFB1 toxicity by plant allelochemicals in H. zea may result 
from the involvement of CYP321A1 and other P450 and non-P450 detoxification 
systems.  
The complete detoxification pathway for AFB1 in H. zea is not yet clear. In 
vertebrates, disposal of AFBO, a P450-mediated bioactivation product, represents an 
important detoxification pathway. Although the PBO inhibition assay of Zeng et al. 
(2006) provided evidence for the existence of AFB1 bioactivation processes in H. zea 
larvae that are P450-mediated, it is also possible that this compound, typically a P450 
inhibitor, induces expression of detoxicative P450s, such as CYP321A1. This 
scenario is consistent with the AFB1 metabolic profiles characterized in vitro in two 
other insects, navel orangeworm (Amyelois transitella) and codling moth (Cydia 
pomonella) (Lee and Campbell, 2000). With more sensitive techniques used for 
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detection of AFB1 metabolites and more functional studies of H. zea P450s, future 
experiments will resolve these possibilities.  
Providing further insight into our demonstration that CYP321A1 
O-demethylates AFB1 to AFP1 while CYP6B8 does not, predictive AFB1-docked 
models derived for CYP321A1 and CYP6B8 suggest that the heme proximal region 
of the CYP321A1 catalytic site is large enough to allow AFB1 to approach within 
reactive distance of the iron-oxo intermediate. The significant reductions in the 
volume of this region predicted for the CYP6B8 catalytic site position the rigid AFB1 
structure at a non-reactive distance from the heme oxygen. Among the many variable 
residues differentiating these catalytic sites, two bulky residues in CYP6B8 (F118 in 
SRS1, Q375 in SRS5) are the most likely contributors to the reduction in its catalytic 
site volume.   
Since the discovery of the contributions of insect damage to aflatoxin 
contamination of crops in the early 1960s, attention has focused only recently on the 
competing mechanisms mediating aflatoxin detoxification and bioactivation in 
insects. Our identification of H. zea CYP321A1 as the major inducible P450 capable 
of detoxifying AFB1 to the more polar and less toxic AFP1 metabolite clarifies one 
mechanism by which phytochemicals enhance resistance to mycotoxins encountered 
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Fig. 1 HPLC chromatograms showing AFB1 metabolites generated by proteins 
isolated from midguts of H. zea fed on diets containing 1 mg/g coumarin. 
Metabolic reactions were carried out as described in Materials and Methods. Two 
metabolites, Met1 (retention time 7.0 min) and Met2 (retention time 7.4 min) were 
generated in the presence of NADPH (panel B) and not in its absence (panel A). 
AFG1 (retention time 10 min) represent the internal standard used for normalization 












Fig. 2 LC-MS analysis of AFB1 metabolites. LC-MS analysis of metabolites 
showed that positive ionization of AFB1 metabolite Met1 (retention time 7.0) 
generates a compound with a molecular weight of 299.2. Deduction of a positive ion 
from this ionized metabolite results in a molecular weight of 298 which matches the 


































Fig. 3 CYP321A1 kinetics. CYP321A1 coexpressed with house fly P450 reductase 
was assayed for AFB1 metabolism at varying substrate concentrations. The 
disappearance rate was calculated relative to P450 content in units of nmol AFB1 
metabolized/min/nmol P450. The means with error bars represent the average of two 














Fig. 4 Induction levels of CYP321A1 transcripts by different phytochemicals.  
100 ng total RNA pooled from 20 midguts of newly molted fifth instar H. zea larvae 
reared on control diet or diets containing 0.2% DMSO, 1 μg/g AFB1 and 
phytochemicals (1 mg/g indole 3-carbinol, 1 mg/g coumarin, 0.5 mg/g xanthotoxin) 
for 48 hr were RT-PCR amplified with CYP321A1 and actin gene-specific primers. 
(A) The amplified products were Southern blotted and probed with 32P-labeled 
CYP321A1 and actin cDNA fragments as described in Materials and Methods and 
exposed and quantified by Phosphorimager. The CYP321A1 induction levels were 
calculated after normalization to the constitutive actin mRNA levels in each sample 
and are recorded relative to the negligible CYP321A1 levels in control larvae reared 
on a diet supplemented with only 0.2% DMSO. (B) The means of three independent 






Fig. 5 AFB1-docked P450 models. Overlays of the AFB1-docked models built for 
the CYP321A1 and CYP6B8v1 proteins are shown with identical residues within 
contact distance (<4.5 Å) of AFB1 identified in aqua (R104/R104 in SRS1 is on the 
right, A305/A303 and E308/E306 in SRS4 are on the left) and variable residues in 
elemental colors. The two residues having highest impact on these active site 
volumes (F118/T119, Q375/T373) are labeled according to their identity in 
CYP6B8v1/CYP321A1. AFB1 is shown in CYP321A1 in orange ball-and-stick 










V Characterization of xenobiotic-metabolizing cytochrome P450s from Amyelois 
transitella (Walker) (navel orangeworm) 
Abstract 
The navel orangeworm Amyelois transitella (Walker) (NOW: Lepidoptera: 
Pyralidae) is a serious pest in California orchards and damages many crops including 
almonds, pistachios, walnuts and figs. To understand the molecular mechanisms 
underlying detoxification of phytochemicals, insecticides and mycotoxins by this 
species, three full-length cytochrome P450 monooxygenase cDNAs, CYP6AB11, 
CYP321C1 and CYP6B44, were isolated from larval midguts using Rapid 
Amplification of cDNA Ends PCR. Evolutionary relationships between these insect 
P450s and others with known functions were established by phylogenetic analysis. 
Metabolic assays conducted with baculovirus-expressed P450, P450 reductase and 
cytochrome b5 samples and sixteen compounds, including phytochemicals, 
mycotoxins, and synthetic pesticides, showed that CYP6AB11 can efficiently 
metabolize imperatorin (0.88 pmol/min/pmol P450) and slowly metabolize piperonyl 
butoxide (0.11 pmol/min/pmol P450). LC-MS analysis indicated that the metabolite 
of imperatorin is the epoxide generated by oxidation of the double bond in its 
isoprenyl side chain. The predicted structure of CYP6AB11 suggests that its catalytic 
site contains a doughnut-like constriction over the heme that excludes aromatic rings 
on substrates and allows only their extended side chains to access the catalytic site. 
That CYP6AB11 can metabolize the principal insecticide synergist, piperonyl 
butoxide (PBO, a methylenedioxyphenyl synergist), in use to circumvent resistance 
raises the possibility that, once acquired, insecticide resistance in this species may be 









Cytochrome P450 monooxygenases (P450s) comprise a superfamily of 
heme-thiolate enzymes in most aerobic organisms (Ortiz de Montellano, 2005). The 
reactions catalyzed by eukaryotic microsomal P450s are oxidations that release a 
water molecule through an electron-transport system involving cytochrome P450 
reductase and cytochrome b5. In insects, P450s metabolize many endogenous 
compounds critical for growth and development, including steroid hormones, 
juvenile hormones, and fatty acids (Feyereisen, 1999, 2006; Li et al., 2007). They are 
also important phase I detoxification enzymes converting a wide range of xenobiotics 
to more hydrophilic metabolites, which are excreted either directly or after 
conjugation to glucuronides or glutathiones mediated by phase II detoxification 
enzymes (Feyereisen, 1999, 2006; Li et al., 2007).  
The many P450s in eukaryotes have been subdivided into 4 major clades 
(clans or subclasses) (Nelson, 1998; Feyereisen, 2006; Baldwin et al., 2009). Clade 3 
in insects is further subdivided into the CYP6 and CYP9 families, which appear to 
participate primarily in xenobiotic metabolism (Feyereisen, 1999, 2006; Scott and 
Wen, 2001; Li et al., 2007).Within the genus Papilio (Lepidoptera: Papilionidae), 
CYP6 family members are known to detoxify furanocoumarins, secondary 
metabolites characteristic of the host plant families consumed by these insects 
(Cohen et al., 1992; Hung et al., 1995a, b, 1997; Wen et al., 2003, 2005, 2006a, b; Li 
et al, 2003; Pan et al., 2004). Across four Papilio species, close to a dozen P450s 
have been demonstrated to metabolize furanocoumarins; these include CYP6B1 and 
CYP6B3 from P. polyxenes (Cohen et al., 1992; Hung et al., 1995a, 1995b, 1997; 
Wen et al., 2003, 2005, 2006a, b; Pan et al., 2004), CYP6B4, CYP6B17 and CYP21 
from P. glaucus (Li et al., 2002, 2003); CYP6B25 and CYP6B26 from P.  
canadensis (Li et al., 2003), and CYP6B33 from P. multicaudatus (Mao et al., 2007a, 
2008a). Beyond the Papilionidae, other P450s in Clade 3 are known to metabolize 
furanocoumarins; these include CYP6AB3v1 and CYP6AB3v2 from the oecophorid 
Depressaria pastinacella (Mao et al., 2006b, 2007b, 2008b), which is a specialist on 
only two genera of furanocoumarin-containing plants, and CYP6B8 and CYP321A1 
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from Helicoverpa zea (Li et al., 2000, 2004; Sasabe et al., 2004; Rupasinghe et al., 
2007), which is a polyphagous noctuid occasionally encountering furanocoumarins in 
a small number of its hostplants.  
In general, across all lepidopteran families examined to date, P450 activity 
against furanocoumarins is correlated with the frequency with which these 
compounds are encountered in hostplants (Li et al., 2000, 2002, 2004, 2007; Mao, 
2006a, b, 2007a, b, 2008a, b). CYP6AB3 from D. pastinacella, a specialist that feeds 
on reproductive structures of two furanocoumarin- containing host species, is the 
most specialized insect xenobiotic-metabolizing P450 yet characterized (Mao et al., 
2006b, 2007b, 2008b). Of the many prospective substrates existing in its hostplants, 
this enzyme can metabolize only imperatorin, a linear furanocoumarin, and myristicin, 
a naturally occurring methylenedioxyphenyl (MDP) compound (Mao et al., 2006b, 
2007b). By contrast, CYP6B8, a P450 identified from Helicoverpa zea, a highly 
polyphagous species recorded from over 100 plant species in many families, is able 
to metabolize many different structurally diverse classes of chemicals, including 
furanocoumarins, flavonoids and insecticides (Li et al., 2000, 2004; Rupasinghe et al., 
2007).  
The navel orangeworm Amyelois transitella is, like H. zea, a broadly 
polyphagous pest of a wide range of crop plants that in California orchards causes 
extensive damage to almonds, pistachios, walnuts, pomegranate, and figs (Connell, 
2001; Campbell et al., 2003; Molyneux et al., 2007). In almond orchards, eggs are 
laid on mummy nuts on trees and larvae bore into nuts and eat their nutmeat until 
pupation. NOW also serves as a vector for the aflatoxin-releasing fungi Aspergillus 
flavus and A. parasiticus (Widstrom, 1979; Schatzki and Ong, 2000, 2001; Campbell 
et al., 2003) when wounds in fruits caused by NOW damage facilitate entry of spores. 
NOW infestations have often been linked with substantial aflatoxin contamination, 
rendering the crop unmarketable (Schatzki and Ong, 2000, 2001; Campbell et al., 
2003). Demand for almonds worldwide is reaching unprecedented levels, leading to 
rapid expansion of almond acreage. Accordingly, to meet export requirements for 
aflatoxin contamination, minimizing NOW infestations is an important priority.  
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In comparison with most other insects, NOW is remarkably resistant to 
aflatoxin toxicity (Niu et al., 2009) due at least in part to its extremely active P450 
detoxification system that can efficiently convert aflatoxin B1 (AFB1) into less toxic 
metabolites, including aflatoxin M1 (AFM1), aflatoxin B2a (AFB2a) and aflatoxicol 
(AFL) (Lee and Campbell, 2000). This active P450 detoxification system is likely 
also involved in allowing NOW to thrive on a broad range of chemically distinctive 
hostplants and may also serve as a preadaptation for acquiring resistance to synthetic 
organic insecticides. The absence of completely effective cultural or biological 
controls growers have remained heavily reliant on insecticides for NOW management.  
To better characterize the range of P450s contributing to xenobiotic metabolism in 
this species, we have cloned three full-length P450 cDNAs expressed constitutively 
in NOW larvae and expressed these in baculovirus-infected Sf9 insect cells. Their 
catalytic sites and predicted substrate binding modes have been predicted and 
compared with close relatives and with their observed metabolic activities.  
2.  Experimental procedures 
2.1 Reagents 
Four furanocoumarins (xanthotoxin, angelicin, bergapten, imperatorin),  
a coumarin (coumarin), a phenylpropanoid (myristicin), four flavonoids (quercetin, 
kaempferol, flavone, α-naphthoflavone), a phenolic acid (chlorogenic acid), a 
mycotoxin (AFB1, and two synthetic compounds (the insecticide α-cypermethrin, the 
synergist PBO) were used to test substrate specificity of heterologously expressed 
P450 proteins. All of these compounds and nicotinamide adenine dinucleotide 
phosphate (NADPH) were purchased from Sigma (St. Louis, MO). Three additional 
insecticides tested, aldrin, diazinon and methoprene, were bought from Indofine 
Chemical Company Inc. (San Francisco, CA). Reagents for heterologous expression 
in Sf9 insect cells, including Sf9 insect cells, SF-900 serum-free medium, and fetal 
bovine serum (FBS), were purchased from GibcoBRL/Life Technology (Grand Island, 
NY). All of the chemicals were dissolved in methanol and prepared as 10 mM stock 
solutions stored at -20oC. All HPLC solvents were bought from Fisher Scientific 
L.L.C. (Pittsburgh, PA, USA). House fly P450 reductase and fruit fly cytochrome b5 
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recombinant viruses were constructed by Dr. Zhimou Wen.  
2.2 Insects 
A laboratory colony of NOW was established and subsequently enriched 
with specimens generously provided by Dr. Joel Siegel from California. The colony 
was maintained in an insectary at University of Illinois at Urbana-Champaign at 28 ± 
4° C with16-h L/8-h D light cycle. NOW larvae were reared in 1000 ml plastic cups 
plastic cups with small holes punched in the lid containing a wheat bran diet as 
described by Tebbets et al. (1978) and modified by Dr. Siegel (personal 
communication). NOW moths emerged approximately one month after the first instar 
stage. For breeding, around 20-30 adults were transferred to a clean 1000 ml plastic 
cup with a piece of tissue paper placed inside the cup and a piece of tissue paper 
covering the top. 
2.3 Isolation of the full-length cDNA from Amyelois transitella. 
2.3.1 RNA isolation and 3’ RACE PCR amplification  
Total RNA was extracted from 30 midguts dissected from larvae one day 
after molting to the final instar using TRIzol reagent (Invitrogen, Carlsbad, CA) 
according to manufacturer’s directions. Superscript II (Invitrogen) was used to 
synthesize the first strand with C3PT as the oligo (dT)17 primer (Table 1) and 1 µg of 
total RNA as the template. The first strand cDNA was purified using a QIAquick 
PCR purification kit (Qiagen, Valencia, CA) to remove the primers and short cDNA; 
this product then became the 3’ RACE Ready DNA for use in the next RACE 
amplification.  
A degenerate primer based on the conserved amino acid sequence of FDPER 
approximately 80 nucleotides upstream of the heme-binding region (Li et al., 2004) 
and a C3 adaptor primer (Table 1) were used to amplify putative 3’ cDNA sequences 
of P450 genes. The PCR reaction (50 µl) was heated to 94°C for 5 min, followed by 
30 cycles of amplification (94°C for 30 sec, 55°C for 30 sec and 72°C for 1 min) and 
followed by a final extension at 72°C for 10 min. After 1.5% agarose gel 
fractionation of the PCR products, DNA fragments in the size range of 300-700 bp 
were cut out, purified using a QIAquick gel extraction kit (Qiagen) and cloned into 
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the pGEM-T-easy vector (Invitrogen). Recombinant plasmids were isolated from 46 
positive clones and their inserts were sequenced from both ends by the Core DNA 
Sequencing Facility at UIUC using vector primers. Among these clones, nine putative 
P450s fragments corresponding to three independent P450 sequences were identified 
by BLAST analysis. 
2.3.2 5’ RACE PCR 
The 5’ ends of these three P450 sequences were amplified with the 
SMARTTM RACE cDNA Amplification kit (Clontech, Mountain View, CA) 
following the manufacturer’s instructions. First-strand cDNA synthesis was 
performed using 1 µg total RNA, 1 µl CDS primer A and 1 µl SMART II A oligo and 
add sterile water to a final volume of 5 µl. After the mixture was incubated at 70°C 
for 2 min and cooled on ice for 2 min, 2 µl 5×First-strand buffer, 1µl 20 mM DDT, 1 
µl 10 mM dNTP mix and 1 µl MMLV reverse transcriptase were added and the 
mixture was incubated at 42°C for 1.5 hr. After this incubation, the final mixture was 
diluted with the addition of 100 µl Tricin-EDTA buffer. and the 5’ RACE PCR 
amplification was set up by mixing 1 µl 10 mM of a gene-specific primer 
(62SM-GSP1, 34SM-GSP1 or 55SM-GSP1) (Table 1), 5 µl 10× Advantage PCR 
buffer, 1 µl 10 mM dNTP, 1 µl 50× Advantage 2 Polymerase Mix, 5ul 10× UPM 
primer stock and sterile water to a final volume of 50 µl. A PCR amplification 
reaction was set up sequentially with a program of 1 cycle at 94 °C for 5 min; 5 
cycles at 94 °C for 30 sec, 72 °C for 3 min; 5 cycles at 94 °C for 30 sec, 70 °C for 30 
sec, 72 °C for 3 min; 30 cycles at 94 °C for 30 sec, 68 °C for 30 sec, 72 °C for 3 min; 
the final extension at 72 °C for 10 min.  
The reaction mixture was then diluted 50 times and 5 µl of the diluted 
PCR product was used to set up a nested PCR amplification with 1 µl 10 mM of a 
nested gene-specific primer (62SM-NGSP1, 34SM-NGSP1 or 55SM-NGSP1) and 5 
µl 10×UPM primer stock. These reactions were PCR amplified with 1 cycle at 94 °C 
for 5 min; 25 cycles at 94 °C for 30 sec, 68°C (55SM-NGSP1 and 62SM-NGSP1) or 
64°C (34SM-NGSP1) for 30 sec, 72 °C for 3 min; 1 cycle of final extension at 72 °C 
for 10 min. The PCR products were electrophoresed on a 1% agarose gel and those at 
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approximately 1.5 kb were excised and purified using a QIAquick gel extraction kit 
and then cloned into pGEM-T-easy vector. Plasmid DNAs isolated from white 
colonies on plates containing ampicillin, isopropyl β-D-1-thiogalactopyranoside 
(IPTG) and X-gal were sequenced at the Core DNA Sequencing Facility at UIUC.  
2.3.3 Generation of the full length cDNA 
The 3’ RACE-Ready cDNA described above was used as the template 
with a 5’ gene-specific primer (GN6AB11_CDS_forward, GN6B44_CDS_forward, 
or GN321C1_CDS_forward) corresponding to the start codon and a 3’ gene-specific 
primer (GN6AB11_CDS_revserse, GN6B44_CDS_reverse, or 
GN321C1_CDS_reverse) corresponding to the stop the codon was mixed with other 
PCR components including 2.5 µl 3’ RACE cDNA, 1 µl Advantage 2 polymerase, 
and 5 ul 10× Advantage PCR buffer, 1 µl dNTP (10 mM) and sterile water to a final 
volume of 50 µl. The PCR amplification was conducted with with 1 cycle at 94°C for 
5 min, 30 cycles at 94°C for 30 sec, 60°C for 30 sec, 72°C for 2 min and followed by 
a final cycle at 72°C for 10 min. The PCR products were electrophoresed on a 1% 
agarose gel and each approximately 1.5 kb fragment was excised and purified with a 
QIAquick PCR purification kit (Qiagen). To insert the PCR product into the pFastbac 
vector for sequencing and expression, the purified PCR product and pFastbac vector 
were digested with enzymes whose recognition sites were incorporated into their 
primers (Table 1) and purified with a QIAquick PCR purification kit. A ligation 
reaction was conducted in a reaction mixture containing 3 µl (150 ng) PCR product, 1 
µl (100 ng) pFastbac, 1 µl T4 DNA ligase (Invitrogen), 1 µl 10×T4 DNA ligase 
buffer and 4 µl sterile water and incubated at 4°C overnight. The ligated DNA was 
transformed into Top10 competent cells (Invitrogen), plated on ampicillin plates and 
plasmids were isolated with QIAprep Spin Miniprep Kit (Qiagen) from the 
ampicillin-resistant colonies and sequenced at the Core DNA Sequencing Facility at 
UIUC.  
2.4 Phylogenetic analysis  
A phylogenetic analysis was performed for the 15 protein sequences 
selected to represent lepidopteran P450s involved in xenobiotics metabolism ; these 
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included were CYP6B1 from P. polyxenes (black swallowtail), CYP321A1 and 
CYP6B8 from H. zea (corn earworm), CYP6B10 from tobacco budworm Heliothis 
virescens (tobacco budworm), CYP6B11 from Papilio Canadensis (Canadian tiger 
swallowtail), CYP6B12 from P. glaucus (Eastern tiger swallowtail), CYP6B29, 
CYP6AB4 and CYP6AB5 from Bombyx mori (domesticated silkworm), CYP321C1, 
CYP6AB11 and CYP6B44 from A. transitella, CYP6AB3v1 and CYP6B7 from D. 
pastinacella (parsnip webworm) and CYP321B1 from H. armigera (cotton 
bollworm). A phylogenetic tree was built using the neighbor-joining method in Mega 
3.0 software and the inferred phylogeny was tested by bootstrap analysis with 1000 
replicates (version 3.1, Kumar et al., 2004). The alignments, with amino acid 
substitutions labeled as strongly conservative, weakly conservative or 
nonconservative, were generated with ClustalW functions in SDSC Biology Software 
(http://workbench.sdsc.edu). The substrate recognition sites (SRS) regions in these 
proteins were determined by alignment with the CYP6B8 and CYP321A1 sequences 
described in Rupasinghe et al. (2007).  
2.5 Baculovirus expression of A. transitella P450s 
The CYP6AB11, CYP6B44 or CYP321C1 cDNA was introduced into the 
pFASTBac baculovirus expression vector as described in Niu et al. (2008) by 
transposing the pFASTBac clones containing the cDNA into DH10 competent cells 
and selecting on kanamycin/gentamicin/tetracycline/blue-gal/IPTG plates. 
Recombinant bacmid DNAs were isolated with a QIAprep Spin Miniprep kit 
(Qiagen), with the except of that, due to the large size of the bacmid DNA (>135kb), 
the isolated DNA was washed once with 70% alcohol instead of being column 
purified (as for smaller plasmids). To determine whether the P450 sequence was 
successfully inserted into the bacmid vector, PCR amplifications were conducted 
with an internal gene-specific primer (Table 1) and a M13 vector primer and the 
products were electrophoresed on 1% agarose gels. The recombinant viruses were 
generated by transfecting 1.5 µg (5µl) recombinant bacmid DNA containing the 
correctly sized insert into Sf9 cells using Cellfectin Reagent (Invitrogen) following 
manufacturer’s procedure. The recombinant baculoviruses were harvested after 72 hr 
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and amplified by infecting Sf9 cells with 500 µl of the recombinant virus stock and 
collecting the amplified virus particles after 48 hr. Plaque assays were used to 
determine the virus titer.   
The P450 protein was co-expressed in Sf9 cells with two redox partners, 
house fly P450 reductase and fruit fly cytochrome b5, and the P450 content of each 
sample was determined by reduced CO difference analysis (Omura and Sato, 1964). 
In preliminary assays, the MOI (multiplicity of infection) ratios of the P450, P450 
reductase and cytochrome b5 were varied to balance P450 production and activity. In 
the final assays, the MOI ratio (P450: P450 reductase: cytochrome b5) used for 
1:1:0.1 (CYP6AB11), 1:1:0.1(CYP321C1) and 1:0.5:0.1 (CYP6B44). The infected 
cells were grown at 28°C and harvested after 72 hr with 10 µl 5 mg/g heme stock 
dissolved in 50% ethanol and 50% 1N NaOH added to each 10 ml culture plate 24 hr 
after the initial transfection. After this incubation, the virus particles were precipitated 
by centrifugation at 5,000 rpm for 10 min at 4°C and the cell pellets were washed 
once with an equal amount of 0.1 M phosphate buffer (pH 7.8) and resuspended in 
one-tenth volume cell lysis buffer [0.1 M phosphate buffer (pH 7.8), 1 mM EDTA, 
0.5 mM PMSF, 0.1 mM DTT, 20% glycerol]. The resuspended pellets were sonicated 
for 15 sec per ml of protein pellet, centrifuged at 5,000 rpm for 10 min, and the final 
supernatant was frozen in liquid nitrogen and stored at -80°C prior to metabolism 
assays.  
2.6 Metabolism assays by the heterologously expressed P450s 
Metabolism assays were carried out in 0.5 ml reactions containing 0.1 M 
phosphate buffer (pH 7.8), 0.3 nmol P450 in cell lysis buffer and 10 nmol substrate. 
Reaction were initiated with the addition of 50 nmol NADPH and incubated at 30°C 
for 1 hr or longer with shaking and stopped with the addition of 100 µl of 1 M HCl. 
For the samples analyzed by either normal-phase HPLC or GC-MS, 400 µl of ethyl 
acetate including an internal standard (Table 2) were added to each reaction and the 
reaction mixtures were centrifuged at 10,000 rpm for 10 min at room temperature, 
after which 1 µl or 10 µl ethyl acetate extracted phase was injected for analysis. For 
the samples analyzed by reverse-phase HPLC, 0.5 ml acetone was added to each 
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reaction, samples were centrifuged at 10,000 rpm for 10 min and then 10 µl sample 
was injected into the reverse-phase HPLC for analysis. Details of the analytical 
methods are summarized in Table 2. The turnover rates of the parent compounds due 
to the activity of the P450 proteins were calculated based on substrate disappearance. 
Each metabolism assay was replicated three times.  
2.7 Identification of the metabolite of imperatorin 
The imperatorin metabolite generated by CYP6AB11 was analyzed by 
reverse phase HPLC to separate the metabolite from its parent compound. For this, a 
200 µl aliquot of the ethyl acetate extracted phase from a 0.5 ml metabolism reaction 
containing 0.3 nmol P450 and 10 nmol imperatorin smf incubated for 1 hr at 30oC 
was dried under nitrogen and then dissolved in methanol. A 10 µl sample was 
injected onto the reverse-phase HPLC according to the method described in Table 2. 
After this, a 10 µl sample from the same reaction was examined by LC-MS 
(Shimadzu, model 2010EV, Kyoto, JP) using positive electrospray ionization (ESI) 
with the same solvent system but with a Luna C18 column (250 mm x 2 mm, 5 μm, 
Phenomenex).  
2.8 Molecular modeling and substrates docking in the P450s  
P450 structures were predicted using MOE programs (Chemical 
Computing Group Inc., Montreal, Canada) as previously described in Rupasinghe et 
al. (2003) and Mao et al. (2006b) using several templates, including CYP2C5 (1N6B; 
Wester et al., 2003), CYP2C8 (1PQ2; Schoch et al., 2004), CYP2C9 (1OG5; 
Williams et al., 2003), CYP3A4 (1TQN; Yano et al., 2004) and CYP102 (2HPD; 
Ravichandran et al., 1993). After energy minimization with CHARMm22 force field 
(MacKerell et al., 1998), each model was tested for its quality with Profiles 3D 
(Insight Homology Accelerys, CA, USA) and ProsaII (CAME Salzburg, Austria) and 
the best model was selected for substrate docking experiments. 
The energy-minimized substrate-free protein structures were docked with 
substrate molecules, using the Monte-Carlo docking procedure of MOE with the 
MMFF94s force field (Halgren, 1996) for the oxygen-free heme as distributed in 
MOE 2004. The structures were initially placed above the heme plane and allowed to 
89 
vary through Monte-Carlo simulations. Hundreds of possible conformations were 
generated for each substrate inside the catalytic site and ranked according to the sum 
of the ligand's internal energy, van der Waals and electrostatic energy terms of the 
potential energy function. The lowest energy conformation was selected as the most 
feasible binding mode; the binding energy for each compound was calculated using 
the MMFF94s force field and the best-ranked binding modes for each compound 
were selected, included in the protein, and energy-minimized, assuring that the final 
energy gradient was less than 0.01 kcal/mol per Å. In the protein/ligand 
minimizations, the heme coordinates were kept fixed to avoid any distortion of the 
heme plane due to the lack of bonded parameters for the heme in the MMFF94s force 
field. Interaction energies between the minimized protein and the ligand were 
calculated as the difference between the total potential energy of the minimized 
complex and the sum of the individual protein and minimized components of the 
complex. Amino acids within a 4.5 Å radius around the substrate were selected as 
substrate contact residues and secondary structural elements containing these residues 
were selected as SRS. 
3. Results 
3.1 Gene analysis of P450s identified from A. transitella 
To identify P450s involved in detoxification of phytochemicals, 
insecticides and mycotoxins, full-length P450 cDNAs from NOW larval midguts 
were amplified using 3’ RACE strategies with a degenerate primer corresponding to 
the conserved FDPER region in P450s approximately 30 amino acids upstream of the 
heme-binding region. These 3’ RACE clones were subsequently extended to their 
translation start sites using 5’ RACE strategies and gene-specific primers. The 
isolated P450 cDNAs classified as CYP6AB11 (516 amino acids), CYP321C1 (496 
amino acids), CYP6B44 (502 amino acids).  
Of more than 1800 P450 sequences identified from insects, those in the 
CYP6B and CYP6AB subfamilies and CYP321 family have been isolated 
exclusively from lepidopterans. Among these, 48 CYP6B genes are distributed across 
fourteen species, 12 CYP321 genes are distributed across seven species and 13 
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CYP6AB genes are distributed across five species (Table 2). Primary sequence 
alignments of these three protein sequences indicate that CYP6B44 shares 50-54% 
identity with other CYP6B proteins ranges, CYP321C1 shares 52% identity with 
CYP321A1 and 50% identity with CYP321B1, and CYP6AB11 shares 67% identity 
with CYP6AB4 (Fig. 1).  
Comparisons of SRS regions in P450s with those in their close relatives 
indicate that amino acid identities in SRS4 (I helix) of these proteins are higher than 
in other SRS domains (SRS2, SRS3, SRS6), with up to 77% identity among all of 
selected P450s within each subfamily or family (Fig. 2). More specifically, 
comparisons of CYP6B44 and other CYP6B genes, 39 are absolutely conserved 
amino acids, 11 are strongly conserved, 11 are weakly conserved and 24 are not 
conserved (Fig. 2A). For CYP321C1 and CYP321A1 show that of the 84 amino acids 
in the SRS regions, of which 46 are absolutely conserved amino acids, 19 are 
strongly conserved, 8 are weakly conserved and 11 are not conserved (Fig. 2B). Of 
the 88 amino acids in the SRS regions of the CYP6AB proteins, 39 amino acids are 
absolutely conserved, 15 amino acids are strongly conserved, 3 amino acids are 
weakly conserved and 31 amino acids are not conserved (Fig. 2C).  
3.2 Characterization of the substrates of the P450s from A. transitella 
To characterize the substrates for the P450s isolated from NOW, the P450 
cDNAs were co-expressed in Sf9 insect cells with house fly P450 reductase cDNA 
and fruit fly cytochrome b5 cDNA. Expression conditions were optimized by 
adjusting the ratio of P450: P450 reductase:cytochrome b5 to achieve maximum 
activity toward test substrates. The sixteen chemicals tested to determine their 
suitability as substrates were selected based on the predicted structures of these P450s, 
availability in recorded hostplants and analogy with similar P450s having known 
substrates. Among them, coumarin, xanthotoxin, angelicin, imperatorin and bergapten, 
flavone and α-nathoflavone have previously been determined to be metabolized by 
CYP6B proteins (Hung et al., 1997; Chen et al., 2002; Li et al., 2003, 2004; Wen et 
al., 2003, 2006b; Mao et al., 2007b) and H. zea CYP321A1 (Sasabe et al., 2004; 
Rupasinghe et al., 2007). Myristicin and imperatorin are the substrates for D. 
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pastinacella CYP6AB3 variants (Mao et al., 2006b, 2007b, 2008b). AFB1 has been 
frequently found in mummy almonds and pistachio housing NOW larvae and is now 
known to be substrate of CYP321A1 (Niu et al., 2008). Quercetin and kaempferol are 
flavonoids that are widely distributed in the hostplants of NOW and chlorogenic acid 
has been isolated from almonds and pistachios (Vaya and Mahmood, 2006; Rubilar et 
al., 2007; Bolling et al., 2009; Teets et al., 2009). Quercetin and chlorogenic acid are 
also efficiently metabolized by H. zea CYP6B8 (Li et al., 2004). In addition to 
natural products, several synthetic insecticides and their synergists were also tested to 
determine their suitability as P450 substrates, including α-cypermethrin, aldrin and 
diazinon and the insecticide synergist PBO. Of these, α-cypermethrin has been 
widely applied in orchards to control NOW (UC IPM online, 2009). Analysis of 
substrate disappearance in these assays (Table 4) indicated that imperatorin is 
efficiently metabolized by CYP6AB11 (0.88nmol/min/nmol P450) and PBO is turned 
over by CYP6AB11 at a slower rate (0.11nmol/min/nmol P450). CYP321C1 did not 
metabolize any of the 16 possible substrates tested in these assays. Only two 
compounds, xanthotoxin and aflatoxin B1, were tested with CYP6B44 but none of 
them can be metabolized.  
3.3 Identification of the metabolite of imperatorin produced by CYP6AB11 
Imperatorin disappearance detected by normal phase HPLC analysis was 
accompanied by the appearance of a new peak eluting at 3.3 min. To further separate 
the metabolite from its parent compound, samples were subsequently analyzed by 
reverse phase HPLC, where the metabolite of imperatorin generated in reactions 
containing NADPH eluted at the retention time of 16.1 min (Fig. 3B). This analysis 
indicated that the metabolite has a spectrum with maximum absorbance peaks at 299 
nm, 249 nm and 213 nm, typical of the spectral characteristics of furanocoumarins 
(Fig. 3C).  
LC-MS analysis was performed to further characterize the structure of the 
imperatorin metabolite.  In positive mode electrospray, the metabolite yields four 
fragments: 203, 269, 287 and 309 (Fig. 4). Like the mass spectrum of imperatorin, 
the metabolite produces a fragment of mass equal to 202 (the plus 1 being 203 m/z), 
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which is equivalent to the fragment obtained from thermal degradation in GC-MS 
and is identical to xanthotoxol, the tricyclic structure with only an alcohol remaining 
from the isoprenyl side chain. The generation of the xanthotoxol fragment indicates 
that the aromatic rings are not the target of this enzyme. The fragment of mass 309 
ion is adduct of the metabolite attached to a sodium ion and the intact metabolite 
appears to be an epoxide formed by the insertion of an oxygen atom into the double 
bond in the isoprenyl side chain. The fragment of mass 286 is equivalent to addition 
of exactly one atom of oxygen and the fragment of mass 287 is the +1 ion of this 
metabolite. The last fragment of mass 268 is an adduct attached to a sodium ion 
which may result from the loss of three carbons at the trailing end of the epoxide. 
This product is identical to that reported for CYP6AB3-mediated metabolism of 
imperatorin, which also appears to target the double bond in the isoprenyl side chain 
(Mao et al., 2006b, 2007b). No metabolite of PBO was observed in our GC-MS 
analysis.  
3.4 Structure predictions and substrate docking 
Alignment of CYP6AB11 with the available mammalian P450 templates 
indicated that the template with the highest sequence identity for CYP6AB11 was 
CYP3A4 (31% sequence identity). The CYP3A4 template was, in fact, used to build 
the original D. pastinacella CYP6AB3 model (Mao et al., 2006b) and we used it as 
the template to predict the CYP6AB11 structure. At the level of primary sequence 
alignments, CYP6AB11 is 55 % identical to CYP6AB3 and the molecular models of 
both proteins are structurally similar. Overlays of their active sites (Fig. 5) indicate 
that most of the active site residues are conserved, particularly those close to the 
heme, where they form a doughnut-like structure similar to that described in the 
CYP6AB3 molecular model (Mao et al. 2006b). Even so, CYP6AB11 and CYP6AB3 
do not exactly align since there are amino acid insertions of Pro105 (in SRS1) and 
Pro235 (between SRS2 and SRS3) in CYP6AB3. Interestingly, all of the amino acids 
creating the doughnut-like structure constricting the catalytic site are conserved 
except for Ile310 (CYP6AB3) vs. Val308 (CYP6AB11) (Fig. 5). Docking of 
imperatorin in the active site predicts that imperatorin binds in the same orientation 
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as in CYP6AB3 but with a slightly higher interaction energy of 38.4 kcal/mol and at 
a slightly greater distance from the heme estimated to be 7.2 Å. The Ile310-to-Val308 
replacement in CYP6AB11 enlarges the opening to the heme and is predicted to 
allow imeratorin to be slightly more mobile than in the CYP6AB3 catalytic site.  
4. Discussion 
Without a fully sequenced genome, characterizing the xenobiotic- 
metabolizing P450 inventory of a particular species is experimentally challenging. 
Our effort to identify the subset of P450s in the NOW genome associated with 
xenobiotic metabolism, however, was greatly facilitated by the use of bioinformatics, 
homology modeling, and comparative ecology, which allowed us to build on prior 
work identifying substrate specificities in related P450s. Thus, we were able to 
demonstrate that CYP6AB11 is able to metabolize imperatorin at a significant rate 
(0.88 pmol/min/pmol P450). Imperatorin is a toxic furanocoumarin that has been 
isolated from a range of plant species in the family Apiaceae (Berenbaum, 1991; 
Berenbaum and Zangerl, 1998; Baek et al., 2000). While NOW has no known 
apiaceous hostplants, it is commonly found on fig (Ficus carica), a moraceous plant 
reported to contain several linear furanocoumarins, including both oxypeucedanin 
and oxypeucedanin hydrate, which, like imperatorin, contain an 8-O-prenylated side 
chain (Zaynoun et al., 1984; Towers, 1986). In other species, furanocoumarins with 
an extended side chain at the 8 position are metabolized by different P450s from 
those which metabolize 8- or 5-methoxy-substituted furanocoumarins. For example, 
whereas CYP6B1 in P. polyxenes, the black swallowtail, metabolizes both 
xanthotoxin (8-methoxypsoralen) and bergapten (5-methoxypsoralen) at high rates, it 
apparently has little to no catalytic activity against imperatorin (Cohen et al. 1992). 
Conversely, CYP6AB3 from D. pastinacella, which is highly active against 
imperatorin, has little to no catalytic activity against either bergapten or xanthotoxin 
(Mao et al., 2006b, 2007b). Among lepidopteran furanocoumarin-metabolizing P450s, 
only CYP6B4 from the polyphagous P. glaucus can metabolizes imperatorin as well 
as 5-methoxy substituted furanocoumarins, possibly because several amino acid 
differences in substrate recognition sites enlarge the catalytic pocket to accommodate 
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a greater range of substrates (Li et al., 2003).  
CYP6AB11 shares 55% identity with CYP6AB3 and, based on a 
comparison of their predicted 3-dimensional structures, also shares a doughnut-like 
structure immediately above the heme that limits substrate access to the catalytic site. 
Key residues limiting access include Phe118 in SRS1 and Ala314 and Thr318 in 
SRS4 and Leu380 in SRS5, which are conserved both in CYP6AB3 and CYP6AB11 
(Fig. 5) (Mao et al., 2006b). This doughnut structure in CYP6AB11 and CYP6AB3 
has not been found in other CYP6 family proteins sequenced to date. The imperatorin 
metabolite generated by CYP6AB11 possesses an epoxide side chain, the result of 
attachment of oxygen to the side chain double bond; the CYP6AB11 model docked 
with imperatorin shows that this substrate can bind in the same orientation as it does 
in CYP6AB3. Comparison of the predicted interaction energies shows that in 
imperatorin would bind in the CYP6AB11 catalytic site with a slightly higher 
interaction energy consistent with the metabolic assay results. The protein alignment 
within the CYP6AB families reveals that CYP6AB11 does not have an Ala92Val 
replacement that characterizes the CYP6AB3v2 variant, which is predicted to greatly 
increase imperatorin metabolism by increasing electron transfer between P450 and 
P450 reductase (Mao et al., 2007b). The absence of this replacement helps to explain 
why the catalytic activity of CYP6AB11 is closer to that of CYP6AB3v1 than that of 
CYP6AB3v2.  
PBO is known as a general P450 inhibitor and has historically been used 
as a synergist applied with pyrethroid insecticides to control insects. It has two rings 
plus a long side chain (C9H19O3) as well as a short side chain (C3H7). Mechanisms of 
PBO metabolism are complex and not fully clear; most studies were completed with 
mammalian P450s have identified more than 10 metabolites, but the specific 
biochemical pathways leading to their formation have not yet been fully elucidated 
(Byard and Needham, 2006). Although CYP6AB11 exhibits low levels of activity 
toward PBO, we were unable to detect a metabolite by GC-MS. Surprisingly, 
CYP6AB11 displayed no consistent detectable activity against myristicin, another 
MDP compound that shares both a core structure and synergistic activity with PBO; 
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myristicin levels declined less than 5% in the metabolism reactions incubated for 2 hr. 
In contrast, CYP6AB3v2 actively metabolizes myristicin (Mao et al., 2008b). 
Because the disappearance rate is close to the detection limit and because the 
disappearance rate is highly variable across replicates, it is still not clear whether 
myristicin can be metabolized by CYP6AB11.  
Although CYP321A1 from H. zea displays activity against a very broad 
range of phytochemical, insecticide and mycotoxin substrates (Sasabe et al., 2004; 
Rupasinghe et al., 2007; Niu et al., 2008), using similar techniques I was unable to 
demonstrate metabolic activity of CYP321C1 against any of the 16 tested chemicals. 
The protein alignment of CYP321C1 with CYP321A1 shows that there is a high level 
of amino acid identity at the back of the catalytic site in the I helix (SRS4) and the 
loop sequences above the catalytic site (SRS3), but there are also many divergent 
amino acid residues in other SRS regions which might be critical for substrate 
channel architecture. Our docking models show that CYP321A1 has a spacious 
cavity allowing larger and more rigid molecules, such as aflatoxin B1, to access its 
catalytic sites. Compared with the CYP321A1 molecular model, CYP321C1 has a 
smaller catalytic core structure which may block access to the catalytic sites for larger 
molecules (data not shown).  
Only two compounds, xanthotoxin and aflatoxin B1, were examined as 
possible substrates for CYP6B44, while previous work with P. polyxenes CYP6B1 
suggested some degree of specialization for furanocoumarin metabolism. No 
metabolism of either compound could be detected with CYP6B44. Amino acids 
critical for metabolism of furanocoumarins in the SRS domains of CYP6B proteins 
include Phe116 and His117 in SRS1, Phe371 in SRS5 and Phe484 in SRS6, which 
are predicted to form a network that stabilizes the catalytic sites and allows the 
furanocoumarins to reach its catalytic core (Chen et al., 2002; Baudry et al., 2003). 
Among them, Phe116 in SRS1 is conserved in all CYP6B proteins and His117 is 
conserved except in CYP6B44 where Asn117 replaces His117. The other amino acids 
including Phe371 in SRS5 and Phe484 in SRS6 are divergent between different 
CYP6B proteins, which may contribute in part to substrate specificity (Fig. 2A). 
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Substitution of Ile115 for Leu115 in SRS1 of CYP6B1 can greatly enhance its 
activity via changes in the metabolite release channel (Pan et al., 2004; Wen et al., 
2005). The fact that the Ile115Leu replacement is found in CYP6B44 should facilitate 
furanocoumarin metabolism. CYP6B8 can metabolize more diverse chemicals than 
the specialized furanocoumarin metabolizing P450s. The molecular model built by Li 
et al. (2004b) shows that CYP6B8 has a larger and more flexible catalytic site than 
CYP6B1 and also has one more substrate access channel than CYP6B1.  
The presence of a seemingly fairly specialized CYP6B11 in the broadly 
polyphagous NOW appears to contrast with previous findings that CYP6B genes in 
polyphagous lepidopterans are as a rule broadly substrate-specific. Our effort to 
identify more substrates by subjecting a whole-plant extract to metabolism assays (cf., 
Mao et al., 2008b) failed to reveal any additional suitable substrates, despite 
considerable chemical complexity present in these extracts. This seemingly 
specialized enzyme may be a historical vestige of a closer association with a 
particular subset of hostplants. Navel orangeworms, as the name suggests, were 
originally described from Citrus spp. (Mote, 1922), although such host use is rarely 
reported today (Mahoney et al., 1989). It is intriguing to note, however, that citrus 
and other rutaceous species are rich in furanocoumarins and may have at some point 
in the evolution of this species represented a major host and selective agent on 
metabolic detoxification pathways. An examination of the host use patterns and 
detoxification capacity of the five congeners of A. transitella may shed light on the 
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Primers Sequences (5’ to 3’) 
FDPER primer GCGGATCCTT(T/C)GA(T/C)CC(I/A)GA(A/G)AG(A/G)TT 
C3PT GAC TCG AGT CGG ATC CAT CGT TTT TTT TTT TTT TTT T 
C3 GAC TCG AGT CGG ATC CAT CG 







Rsr II             Ecor I 
GN6AB11_CDS_reverse GGGCGGCCGCAAGCTTTTAATTAAAATTGACCACATTTCGC 










































xanthotoxin bergapten Normal 
HPLC 
80% cyclohexane, 18% diethyl ether and 2% 
butanol; 1.5ml/min flow rate 
254 5.1 
bergapten xanthotoxin Normal 
HPLC 
80% cyclohexane, 18% diethyl ether and 2% 
butanol; 1.5ml/min flow rate 
254 4.2 
angelicin xanthotoxin Normal 
HPLC 
80% cyclohexane, 18% diethyl ether and 2% 
butanol; 1.5ml/min flow rate 
254 3.1 
coumarin xanthotoxin Normal 
HPLC 
80% cyclohexane, 18% diethyl ether and 2% 
butanol; 1.5ml/min flow rate 
254 3.5 
imperatorin xanthotoxin Normal 
HPLC 
80% cyclohexane, 19% diethyl ether and 2% 
butanol; 1.5ml/min flow rate 
254 3.8 
flavone xanthotoxin Normal 
HPLC 
80% cyclohexane, 18% diethyl ether and 2% 
butanol; 1.5ml/min flow rate 
254 3.9 
α-nathoflavone xanthotoxin Normal 
HPLC 
80% cyclohexane, 18% diethyl ether and 2% 
butanol; 1.5ml/min flow rate 
254 3.0 
quercetin None Reverse 
HPLC 
45% methanol, 55% water in 0.2% acetic acid; 
1ml/min flow rate 
375 20.1 
kamperol None Reverse 
HPLC 
60% methanol, 40% water in 0.2% acetic acid 375 8.9 
chlorogenic acid None Reverse 
HPLC 
7% acetonitrile, 93% water in 0.01% formic 
acid; 1ml/min flow rate 
328 22.1 
imperatorin xanthotoxin Reverse 
HPLC 
Gradient solvent system: pump A Water in 0.05% 
formic acid; B methanol; Start from 80%A for 2 
min; condition the column from 80%A to 
100%B in 13min; remain in 100%B for 5 min; 
condition the column from 100%B to 80%A for 
2 min; remain in 80% A for 10 min. 
254 19.6 
myristicin methoprene GC-MS In the legend.  14.1 
PBO methoprene GC-MS In the legend.  27 
alpha-cypermet
hrin 
methoprene GC-MS In the legend.  32.4 
 
aldrin methoprene GC-MS In the legend.  19.5 
diazinon methoprene GC-MS In the legend.  16.7 
aflatoxin B1 aflatoxin  G1 Reverse 
HPLC 
60% water, 20% acetonitrile;20% methanol; 
1ml/min flow rate 
 14.5 
 
1 Reverse-phase HPLC system consists of Waters 501 pump, Waters WISPC 
autosampler and Waters 996 photodiode array (PDA) and Supercosil LC-18 column 
(250 mm × 4.6 mm). 
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2 Normal phase HPLC system consist of Waters WISP 710B autosampler, Waters 
M-45 solvent delivery system, Waters 440 absorbance detector, Hewlett Packard 
3390A integrator and Waters silica column (4.6*50 µm).  
3 GC-MS system: GC-2010 chromatograph spectrometer, GCMS-QP2010 plus mass 
spectrometer, AOC-20S Shimadzu autosampler and column (Shimadza, Kyoto, JP). 
GC-MS program: injection temperature 290 °C, column temperature starts from 40°C, 
hold for 1 min, 30 °C/min to 130 °C, at 5 C/min to 250 °C, at 10°C/min to 300°C, 
hold for 5 min; ion source temperature 230 °C, interface temperature 280°C. The 
purified helium flow for GC-MS is 1.5 ml/min. The area of the chemical was 




































Table 3 Distribution of individual genes from CYP6B and CYP6AB and 




Insect Species CYP6B CYP6AB CYP321 
Papilio polyxenes 1,3   
Helicoverpa zea 2, 8,9, 27  A1, A2 
Helicoverpa armigera 6,7 9, 10 A1, A3, A4, A5, A6, 
B1, 
Heliothis virescens 10   
Papilio canadensis 11, 13, 14,15, 18, 
19,22, 25, 26 
  
Papilio glaucus 12, 16, 17, 20, 21, 
23,24 
  
Bombyx mori 29 4, 5, 8  
Papilio multicaudatus 30, 32, 33, 34, 35, 36, 
37 
6  
Spodoptera exigua 31,   
Spodoptera frugiperda 38, 39, 40, 41, 42  A7, A8, A9 
Helicoverpa armigera 43   
Amyelois transitella 44  C1 
Manduca sexta 45, 46 13 D1 
Spodoptera litura 47, 48 12  
Trichoplusia ni  1, 2  
Depressaria pastinacella  3, 7  
 





















































 Fig. 1. The phylogenic tree of the genes from CYP6AB, CYP6B and CYP321 in 
insects. The genes tested were from the different insect species (Table 1). The rooted 
phylogenetic tree was constructed using the neighbor-joining method built in Mega 
3.1 and the inferred phylogeny was tested by bootstrap analysis with 500 replicates. 
The branch lengths are proportional to p-distance with numbers representing the 





















CYP6B4        --MLTIFIVTATLFAILYFYFTRNFNYWKDRNVVGPEPTVFFGNIMESVIRRKHLIMIYK60 
CYP6B1        --MLYLLALVTVLAGLLHYYFTRTFDYWKKRNVAGPKPVPFFGNLKDSVLRRKPQVMVYK 
CYP6B8        MWVLYLPAVLSVLIVTLYLYFTRTFNYWKKRNVRGPEPTVFFGNLKDSTLRKKNIGIVME 
CYP6B44       --MIPFILVLITLITTLYYYTTRTLHFWKNKKVLGPKPVALFGNLFEMTTRKKYLGEILK 
                :: :  :  .*   *: * **.:.:**.::* **:*. :***: : . *:*    : : 
                                                     SRS1 
CYP6B4        DIYEAFPKEKVVGIYRMTTPCLLLRDLDVIKHVMIKDFDLFNDRGVEFSEEGLGLNIFHA120 
CYP6B1        SIYDEFPNEKVVGIYRMTTPSVLLRDLDIIKHVLIKDFESFADRGVEFSLDGLGANIFHA 
CYP6B8        EIYNQFPDEKVVGMYRMTTPCLLVRDLDVIKHIMIKDFEAFRDRGVEFSKEGLGQNLFHA 
CYP6B44       DAYNQFPDEKVVGIYTMVTPVLLVRDLDIVKQVTIKDFDVFSDRGTEFSKEGLGANLFNA 
              . *: **.*****:* *.** :*:****::*:: ****: * ***.*** :*** *:*:* 
 
CYP6B4        DGDRWRVLRQCFTPLFTSGKLKNMLNLMSDRGDKFIKMVEKFCDKEPEQQIIPLVRKFTM180 
CYP6B1        DGDRWRSLRNRFTPLFTSGKLKSMLPLMSQVGDRFIKCIDEVSQTQPEQSIHNLVQKFTM 
CYP6B8        DGETWRALRNRFTPIFTSGKLKNMFYLMHEGADNFIDHVSKECEKKQEFEVHSLLQTYTM 
CYP6B44       DGDTWRVLRNYFTPLFTSGKLKNMTYLMTERADNFLNYVDRIVMENPEQEVHKLIQKYTL 
              **: ** **: ***:*******.*  ** : .*.*:. :..    : * .:  *::.:*: 
                                           SRS2 
CYP6B4        ASITTCAFGMELD----EEMIETLDKLDSLIFTTSYGNEIDMMYPGILKKLNSSIFSKMI240 
CYP6B1        TNIAACVFGLNLD----EGMLKTLEDLDKHIFTVNYSAELDMMYPGILKKLNGSLFPKVV 
CYP6B8        STISSCAFGVSYNS--ISDKVQTLEIVDKIISEPSYAIELDYMYPKLLAKLNLSIIPTPV 
CYP6B44       SSISACAFGIDMDIDKENEIVKNISSFDKLIFDISYFIEIIMMFPDLMKKFNTSLFPKSI 
              :.*::*.**:. :    .  ::.:. .*. *   .*  *:  *:* :: *:* *::.. : 
                 SRS3 
CYP6B4        APFFDNLTKTIIEQRGGKPTNRKDLMDLILELRQKKAIEPMKKTHDEQVTTLELTDSVIA300 
CYP6B1        SKFFDNLTKNVLEMRKGTPSYQKDMIDLIQELREKKTLELSRKHENEDVKALELTDGVIS 
CYP6B8        QHFFKSLVDSIISQRNGKPAGRNDFMDLILELRQMG--EVTSNKYLDGVTSLEITDEVIC 
CYP6B44       VNFFYDLVRVVIDERKGAPIGRKDFMDLILELRQQGEIKGTRRG-DDKQLQLDFNEDVIA 
                ** .*.  ::. * * *  ::*::*** ***:    :   .   :    *::.: **. 
                   SRS4 
CYP6B4        AQTFIFYAAGYETSASTMSFLLFELAENPDIQEKVIAEVDETLKRHNGEITYDTLSEMTY360 
CYP6B1        AQMFIFYMAGYETSATTMTYLFYELAKNPDIQDKLIAEIDEVLSRHDGNITYECLSEMTY 
CYP6B8        AQAFVFYVAGYETSATTMSYLIYQLSLNQDVQNKLIAEVDEAIKASDGKVTYDTVKEMKY 
CYP6B44       GQAFAFYVAGYETSATTMTFMLYELARNLDIQKRVLDEIDEVLQRHEGKITYDSVNELNY 
              .* * ** *******:**::::::*: * *:*.::: *:**.:.  :*::**: :.*:.* 
Fig. 2 The protein alignment with the labeled SRS domains of the P450s from 
insects including CYP6AB (Fig. 2A), CYP6B(Fig. 2B) and CYP321(Fig. 2C) 
subfamilies. Fig. 2A The sequences of CYP6B1 (Papilio polyxenes), CYP6B8 and 
CYP321C1 (Helicoverpa zea); CYP6B4 (Papilio glaucus), CYP6B44, CYP321C1 
and CYP6B11v1 (Amyelois tansitella); CYP6AB3v1 and CYP6AB3v2 (Depressaria 
pastinacella) were found from the NCBI protein data base. SRS indicates the 
substrate recognition sites and the amino acids in gray are within SRS regions. 
Consensus key symbols as follows: “*”single, fully conserved residue; 
“:”conservation of strong groups; “.”conservation of weak groups; “no label” 
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represents no consensus.  
 
                           SRS5 
CYP6B4        LTQVFHETLRKYPVADILLRNAKADYAVPGTNVTLKKGQTVVVSGFGIHYDPKYYPDPEK420 
CYP6B1        LSKVFDETLRKYPVADFTQRNAKTDYVFPGTDITIKKGQTIIVSTWGIQNDPKYYPNPEK 
CYP6B8        LNKVFDETLRMYSIVEPLQRKATRDYQIPGTDVVIEKDTMVLISPRGIHYDPKYYDNPKQ 
CYP6B44       MGKVFDETLRMYPVLDSLQRRAQCNYEFPDLGLKIEKGQAVFISPMSIHHDAKHYPNPQT 
              : :**.**** *.: :   *.*  :* .*. .: ::*.  :.:*  .*: *.*:* :*:  
 
CYP6B4        FDPERFSPENVRNRHPCAYIPFGAGQRKCLGMRFGQWQVQVCIIKLLSKFRFEPSTKTMS480 
CYP6B1        FDPERFNPENVKDRHPCAYLPFSAGPRNCLGMRFAKWQSEVCIMKVLSKYRVEPSMKSSG 
CYP6B8        FNPDRFDAEEVGKRHPCAYLPFGLGQRNCIGMRFGRLQSLLCITKILSKFRIEPSKNTDR 
CYP6B44       FDPERFSPENVKNRHPCAYIPFGVGPRNCIGMRFAKVQSRVCMMKLLSKYSVEMTHSTPK 
              *:*:**..*:* .******:**. * *:*:****.: *  :*: *:***: .* : .:   
                   SRS6 
CYP6B4        EFNYDPKRLLVYPKSGIFLNIIPRNY-- 
CYP6B1        PFKFDPMRLFALPKGGIYVNLVRR---- 
CYP6B8        NLQVEPRRVIIGPKGGIRVNIVPRKIVS 
CYP6B44       QVELSPLRLILSPMGGMHLKFNPRY--- 
                  .: .* *::  * .*: :::  *     


























CYP321A1      MLQLPLILLGLVLLLTWYLIGRHNENYWKARGVKFYSKNKVIGPSWDYLFTKGAMFEKFG 
CYP321C1      MFVQIILLIFIVFLFLIYTTGKHNENYWKKRGVKLHKKNKVTGLSWDFFTTDKPVFQIIG 
              *:   ::*: :*:*:  *  *:******* ****::.**** * ***:: *. .:*: :* 
                                                     SRS1 
CYP321A1      ELYKAYRNEPVVAIGQILTPSLFVIDAKNVQHVLSSDFQSFNHRGLDSVEGDQLTESITL 
CYP321C1      DLYKEYREEPAVGFGNFLTPSLLVNDATNIQHIFQTDFQSFNHRGFEINEGDHLADNILF 
              :*** **:**.*.:*::*****:* **.*:**::.:*********::  ***:*::.* : 
 
CYP321A1      LNGPKWKLMRKTMTPLFTSSKLKNMYYIMDKCAQDFVTYLKRDPKLWKGNFFESAMLYCN 
CYP321C1      MNGNRWKLVRQSMTPIFTSTKLKQMFHIMDKSGRDFITYLKDNPERLNGNAIDSISTFCC 
              :** :***:*::***:***:***:*::****..:**:**** :*:  :** ::*   :*  
                                        SRS2 
CYP321A1      AAVCAAIFGIGEQSTFDSPFLKFAKDVSISSFKNNMKFTFFSLAPKLFTMLGLKVFKEHE 
CYP321C1      AAIGAAVFGVESESVFESPFLDVAKRAMKFSVTMNIKALIMNVFPWLSKKLNFKLFSEHE 
              **: **:**: .:*.*:****..** .   *.. *:*  ::.: * * . *.:*:*.*** 
               SRS3                                                SRS4 
CYP321A1      DFFVGAIGDVIKQREEENVKRHDFADLCVQLQKNGTLKDQATGYELEPTTGLLSAQAFFF 
CYP321C1      DFFIGAVKRIIRQREQDKVQKHDFADMCVSLQRNGTLKDRDTGLELEPTDELLSGQAFFF 
              ***:**:  :*:***:::*::*****:**.**:******: ** *****  ***.***** 
 
CYP321A1      FTAGVEPAADGIFATFALLSQHPEILQKVHQEIDEYFEKYDGKITYDVVCDMEYVDKVLS 
CYP321C1      FTAGVDPSAAAIFGCLLELGRNPEHLKKVHNEIDTAFEKLNGNLSYESVMEMEYLEKVLC 
              *****:*:* .**. :  *.::** *:***:***  *** :*:::*: * :***::***. 
                       SRS5 
CYP321A1      ESLRMFPPIGFLTRQCIHDTVLPVGNVKVAKGTKLFTPIYEIHHDPKYYPDPEVFDPERF 
CYP321C1      ESLRMWPPIGVLNRQCVADTVLPVGNIKIDKDTKVYAAVYELHHDPKYYPNPEVFDPERF 
              *****:****.*.***: ********:*: *.**:::.:**:********:********* 
                                                                    SRS6 
CYP321A1      FKERRPNDDLYMPFGMGNRTCIGARYFKLQLLAAIVHVLRSFTLKPIPESQQKKVTFLRH 
CYP321C1      SSTSAQDSNVYMPFGKGNRLCVGMRFARLQVKTGLIHFLRNFTVKTKVDGD--RIRFKKD 
               .    :.::***** *** *:* *: :**: :.::*.**.**:*.  :.:  :: * :. 
 
CYP321A1      AIGVRIGNVKVELIPRDTK 
CYP321C1      PVQVRPVNVDIEFIWRNI- 
              .: **  **.:*:* *:   
Fig. 2B The protein alignment with the labeled SRS domains of the P450s from 









CYP6AB3v2       MYFLIALGILLIILYLYGIKNHKYWEKKGVPYVKPIPFFGTNFKVFMQRICISDQLCKYY 
CYP6AB3v1       MHFLIALGILLIILYLYGIKNHKYWEKKGVPYVKPIPFFGTNFKVFMQRICISDQLCKYY 
CYP6AB11        MIIPIAVIVICLLLYYYGTRNFKYWQKRGIIHDKPIPFFGNNIDGYLFRKSVTQIATDMY 
                * : **: :: ::** ** :*.***:*:*: : *******.*:. :: * .:::   . * 
                                                       SRS1 
CYP6AB3v2       EQFPNEKFVGAFIGDRIGLVLREPELIKRVMATDFQYFHPRGVNPHKTVYEPLLKNLFTG 
CYP6AB3v1       EQFPNEKFVGAFIGDRIGLVLREPELIKRVMVTDFQYFHPRGVNPHKTVYEPLLKNLFTG 
CYP6AB11        RKYPNEKVVGFYRANIPELVVRDPETIKRVLVTDFEHFYPRGIN-HKEVVEPLMRNLFFA 
                .::****.** : .:   **:*:** ****:.***::*:***:* ** * ***::*** . 
 
CYP6AB3v2       DGDMWKLLRQRITPAFTSGKLKAMFPLIVERAERLQIIAATAAQSHGEVDVRELMARFTT 
CYP6AB3v1       DGDMWKLLRQRITPAFTSGKLKAMFPLIVERAERLQIIAATAAESHGEVDVRELMARFTT 
CYP6AB11        DGDLWRLLRQRMTPAFTSGKLKAMFPLIIDCADRLQKRALTVSAAGKKLDARDLMARYTT 
                ***:*:*****:****************:: *:***  * *.: :  ::*.*:****:** 
                                              SRS2 
CYP6AB3v2       DFIGACGFGIDADTLNDEESTFRRLGKRIFTLTRRDGFVFMLKTIAPEIFKNLHMFAPEI 
CYP6AB3v1       DFIGACGFGIDADTLNDEESTFRRLGKRIFTLTKRDGFVFMLKTIAPEIFKNLHMFAPEI 
CYP6AB1         DFIGACGFGVNADSLGDEDSAFRKLGAQIFQPRVQDLIVAILKEVFPDTFKHLKYLS-RL 
                *********::**:*.**:*:**:** :**    :* :* :** : *: **:*: :: .: 
                  SRS3 
CYP6AB3v2       EKTTVDLVTSIMQQRKYKHSGRNDFIDFLLELKGKGKIVGESVEKRNPDGTPKIVEMELD 
CYP6AB3v1       EKTTVDLVTSIMQQRKYKHSGRNDFIDFLLELKGKGKIVGESVEKRNPDGTPKIVEMELD 
CYP6AB11        EDDFKKFVSDVLHLRNYKPSGRNDFIDLMLECKQKGTIVGESIERRDKEGRPEKATVELD 
                *.   .:*:.::: *:** ********::** * **.*****:*:*: :* *: . :*** 
                       SRS4 
CYP6AB3v2       DMLMAAQVFIFFAAGFETSSSTTSYTLHQLAFHPEEQKKCQDQIDEVLSRHGGKLSYEAI 
CYP6AB3v1       DMIMAAQVFIFFAAGFETSSSTTSYTLHQLAFHPEEQKKCQDQIDEVLSRHGGKLSYEAI 
CYP6AB11        DTLIAAQVFVFFAAGFETSSSATSYTLHELAFNPEIQERVQKEIDTVLAKHDNKLSYDAV 
                * ::*****:***********:******:***:** *:: *.:** **::*..****:*: 
                                   SRS5 
CYP6AB3v2       KEMTYLDMIFKESMRMYPSLGILTRRCVQKYTFPGTNLTIDEDVLVCIPVHALHNDEKYF 
CYP6AB3v1       KEMTYLDMIFKESMRMYPSLGILTRRCVQKYTFPGTNLTIDEDVLVCIPVHALHNDEKYF 
CYP6AB11        KEMTYLEWTFKEAMRMLPSLGFLIRQSVRPYTFPELGLSIDADVGIMIPLQALHTDPEYF 
                ******:  ***:*** ****:* *:.*: ****  .*:** ** : **::***.* :** 
Fig. 2C The protein alignment with the labeled SRS domains of the P450s from 










CYP6AB3v2       DEPEKFKPERFSPENIKNIPKYVYLPFGDGPRACIGERLGHMQSLAGLAALLSKFSVAPS 
CYP6AB3v1       DEPEKFKPERFSPENIKNIPKYVYLPFGDGPRACIGERLGHMQSLAGLAALLSKFSVAPS 
CYP6AB11        DNPMEFRPERFDPENFTRKQRDIYLPFGTGPRACIGERLGLMQSLAGLAAVLSKFSVSPA 
                *:* :*:****.***:..  : :***** *********** *********:******:*: 
                         SRS6 
CYP6AB3v2       KNTLRQPITDPTCTVVKSIKGGLPLSLVARKV------ 
CYP6AB3v1       KNTLRQPITDPTCTVVKSIKGGLPLSLVARKV------ 
CYP6AB11        ADTKRWPEIDPRSDIVQTIVGGLPLQFSERKRNVVNFN 
                :* * *  ** . :*::* *****.:  **        
 


















Fig. 3. Reverse-Phase HPLC chromatogram showing imperatorin metabolite 
produced by heterologously expressed CYP6AB11 in insect cells. Metabolic 
reactions were carried out as described in Materials and Methods. The metabolite of 
imperatorin was eluted at 16.1 min in the reaction with addition of NADPH (B) 
compared with the reaction without addition of NAPDH (A). Xanthotoxin as internal 
standard was eluted at 16.6 min. The imperatorin metabolite was scanned with the 
HPLC photodiode array detector and the spectrum of the imperatorin was shown in 








































Fig. 5. Predicted imperatorin binding in CYP6AB11 and CYP6AB3 models. 
Residues around a 4.5 Å radius are shown. Conserved residues are shown in green 
while non-conserved residues are shown in elemental colors. Imperatorin binding 
conformation in CYP6AB3 is shown in aqua and the conformation in CYP6AB11 is 















VI Effects of naturally occurring and synthetic synergists on the toxicity of 
insecticides, phytochemicals and mycotoxins to Amyelois transitella (Lepidoptera: 
Pyralidae) 
Abstract  
The navel orangeworm (NOW), Amyelois transitella, is among the most 
destructive pests of almonds in California as well as a serious problem in pistachios  
(Pistacia vera), figs (Ficus carica) and walnuts (Juglans regia). NOW feeding leaves 
the plants vulnerable to infection by Aspergillus spp., fungi that produce toxic 
aflatoxins. The primary aflatoxin of concern to regulators is aflatoxin B1 (AFB1). 
Due to the extreme carcinogenicity of these mycotoxins, acceptable aflatoxin levels 
in foods in the European Union have been set very low and present a challenge to the 
California tree nut industry. A potentially safe and sustainable approach for managing 
NOW in almond orchards may be to use natural essential oil synergists to interfere 
with this insect’s ability to detoxify mycotoxins, phytochemicals and insecticides. We 
tested the effects of a naturally occurring plant-derived chemical, myristicin (MYR), 
and a synthetic inhibitor of cytochrome P450 monoxygenases (P450s), piperonyl 
butoxide (PBO), on the toxicity of three insecticides (α-cypermethrin, τ-fluvalinate 
and methoxyfenozide), a phytochemical (xanthotoxin) and a mycotoxin (AFB1) to A. 
transitella. The results of the insecticide assays show that α-cypermethrin and 
methoxyfenozide are more toxic than τ-fluvalinate to the newly hatched larvae 
(56-fold and 9.6-fold at 48 hr, respectively). The PBO and myristicin synergism 
bioassays with insecticides show that PBO significantly synergizes cypermethrin and 
fluvalinate and increases their toxicity to NOW, while myristicin synergizes only 
cypermethrin. Neither compound has any significant synergistic effects on 
methoxyfenozide. Synergism bioassays with xanthotoxin demonstrate that PBO 
significantly synergizes the toxicity of this phytochemical over time and that 
myristicin only slightly increases mortality after 7 days. None of the potential 
synergists tested enhanced AFB1 toxicity to NOW larvae. In view of these findings 
and the limited availability of environmentally safe synthetic insecticides for 
sustainable management of NOW, myristicin should be explored as a field treatment 
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to reduce survival of this pest species and aflatoxin contamination in orchard 
situations.  
1. Introduction  
The navel orangeworm (NOW), Amyelois transitella, is among the most 
destructive pests of almonds in California, as well as a serious problem in pistachios, 
figs and walnuts. Neonates tunnel into the nut and successive instars consume the 
nutmeat, generating large quantities of frass and webbing (Bentley et al. 2008). In 
addition to causing such direct losses, NOW feeding leaves almonds vulnerable to 
infection by Aspergillus spp. that produce toxic aflatoxins (Campbell et al., 2003). 
NOW adults lay eggs in mummy fruits when new crop nuts are unavailable (Connell, 
2001; Molyneux et al., 2007) and the caterpillars have been reported as scavengers on 
mummified fruits or nuts of at least 25 plant species (Shelton and Davis, 1994). 
Aflatoxins, considered to be potent hepatocarcinogens, have become a 
serious health issue in many countries, especially in Asia and Africa. As a result, 
strict regulations have been applied to reduce aflatoxin levels in foods (Williams et al., 
2004; Wagacha and Muthomi, 2008). The Food and Drug Administration (FDA) in 
the United States set a maximum 20 ppb limit for total aflatoxins in food, including 
edible nuts, and a maximum 0.5 ppb in milk (Food and Drug Administration, 2006). 
The European Union, one of the principal export targets of the California nut industry, 
sets even lower limits: nuts can contain a maximum level of 8 μg/kg (ppb) aflatoxin 
B1 (AFB1) and 10 μg/kg (ppb) of total aflatoxins 
(http://gain.fas.usda.gov/Recent%20GAIN%20Publications/New%20EU%20Aflatoxi
n%20Levels%20and%20Sampling%20Plan_Brussels%20USEU_EU-27_3-9-2010.p
df). For milk, the maximum level is 0.05μg/kg (ppb) aflatoxin M1 (AFM1) 
(Molyneux et al., 2007) These strict limits have resulted in an increasing frequency of 
rejections of U.S. nuts by the EU due to aflatoxin contamination between 2005 and 
2009; in 2005 alone, 41 rapid alert and information notifications were issued to the 
U.S. (Molyneux et al., 2007). Aflatoxin contamination is seriously challenging the 
California tree nut industry. 
Fungal contamination in orchards is frequently reported to be associated 
119 
with NOW damage and the control of NOW decreases aflatoxin levels in crops 
(Widstrom, 1979; Schatzki and Ong, 2000, 2001; Campbell et al., 2003). Currently, 
NOW management depends on a combination of control tactics, including cultural 
practices and insecticide sprays, particularly when infested adjacent crops, such as 
pistachios, provide immigrants into almond orchards (Higbee and Siegel, 2009). 
Biological control agents, although identified, cannot yet provide complete control. 
Chemical sprays for hull splits include organophosphates and pyrethroids; at present, 
only Entrust (spinosad) sprays are acceptable in organic orchards (Campbell et al., 
2003; Molyneux et al., 2007). Recent studies have demonstrated that A. transitella 
tolerates very high levels of aflatoxin (>100 µg/g) in its diet (Niu et al., 2009) due to 
the activity of detoxification enzymes, including cytochrome P450 monooxygenases 
(P450s) (Lee and Campbell, 2000; Niu et al., 2009). This dependence on P450s for 
aflatoxin tolerance, host phytochemical metabolism and insecticide metabolism 
provides a possible target for control at all stages of growth; naturally occurring 
synergists that inactivate these enzymes should render the NOW more sensitive not 
only to insecticides, allowing the use of lower dosages, but also to host 
phytochemicals and mycotoxins.  
Certain constituents of herbs, spices and other plants are known to inhibit 
growth of aflatoxin-releasing fungi (Rusul and Marth, 1988). Among them, essential 
oils in particular suppress growth and aflatoxin formation by Aspergillus spp. (Belzile 
et al., 2000; Razzaghi-Abyaneh et al., 2008; Singh et al., 2009; Shukla et al., 2009; 
Nogueira et al., 2010). Myristicin (MYR, Fig. 1), a compound found in essential oils 
of several plant species, inhibits the biosynthesis of aflatoxin G1 (AFG1) in 
Aspergillus parasiticus (Razzaghi-Abyaneh et al., 2007). Other important 
plant-derived aflatoxin-inhibitory compounds summarized by Razzaghi-Abyaneh et 
al. (2010) include phenolics (caffeic acid, 3,4-digalloyl quinic acid, chlorogenic acid) 
from Pistacia vera (pistachio), flavonoids (khellin, visnagin) and coumarins 
(xanthotoxin, bergapten, and psoralen) from seeds of Ammi visnaga (toothpick weed), 
one phenylpropanoid (dillapiol) from Anethum graveolens (dill) and two 
phenylpropanoids (apiol, myristicin) from Petroselinum crispum (parsley), phenolics 
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(ferulic acid, vanillic acid, p-coumaric acid) and flavonoids (eriodictyol, 
5,7-dihydroxychromone) from Arachis hypogaea (peanut), phenolics (thymol, 
carvacrol) from Satureja hortensis (summer savory), alkaloids from seeds of Piper 
longum (long pepper), phenolics (vanillic acid, catechin, 4-hydroxybenzoic acid, 
protocatechuic acid) from kernels of Prunus dulcis (almond) and spiroether from 
Matricaria recutita (German chamomile). A new potentially safe and sustainable 
approach for managing NOW in almond orchards may be to use natural essential oil 
synergists to simultaneously suppress caterpillar growth and mycotoxin production in 
almond orchards. Identifying synergistic activity of essential oil constituents 
“generally recognized as safe” (GRAS) (http://www.fda.gov/Food) could lead to 
novel approaches to sustainably manage NOW in both conventional and organic 
almond production.  
In this study, we set out to ascertain the ability of essential oil constituents 
to synergize the toxicity of mycotoxins, hostplant phytochemicals and insecticides 
and subsequently reduce survival of NOW. Some naturally occurring essential oil 
constituents, such as myristicin, are known synergists for certain synthetic 
insecticides (Lichtenstein and Casida, 1963) and phytochemicals (Berenbaum and 
Neal, 1985; Neal, 1989; Neal and Berenbaum, 1989). Piperonyl butoxide (PBO), a 
well-known synthetic inhibitor of P450s and MYR were tested for their synergistic 
activities toward xanthotoxin (XAN) (a constituent of figs) (Murray et al., 1982), 
α-cypermethrin (CPE) and τ-fluvalinate (FLV) (two pyrethroid insecticides), 
methoxyfenozide (MFZ) (an insecticidal ecdysteroid agonist), and AFB1.  
2. Materials and Methods 
2.1 Chemicals  
PBO was purchased from Tokyo Kasei Kogyo (Tokyo, Japan). AFB1, 
MYR (78% purity), CPE, FLV, and XAN were purchased from Sigma Chemicals (St. 
Louis, MO). Methoxyfenozide was obtained from Helena Chemical Company 
(Memphis, TN). All of these chemicals were dissolved in methanol (MeOH) except 
AFB1, which was dissolved in analytical grade dimethyl sulfoxide (DMSO), and 
stored at -20ºC. DMSO and MeOH were obtained from Fisher Scientific (Pittsburgh, 
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PA).  
2.2 Insects  
A laboratory colony of A. transitella originating from an almond orchard 
in Fresno, California that has been maintained for the past 25 years by the 
Commodity Protection and Quality Unit, USDA/ARS (Parlier, CA, USA), was kept 
in an insectary at 28 ± 4° C with 16:8 L:D cycle. Larvae were mass-reared until 
pupation in 500 ml plastic containers containing 200 g of a wheat bran diet (Finney 
and Brinkman, 1967). For bioassays, the newly hatched insects were transferred to 
artificial diets in a 1 oz (30 ml) plastic cup. Adults were transferred to a clean 32 oz 
(900 ml) cup with a piece of tissue paper placed inside the cup and a piece of tissue 
paper covering the top. 
2.3 Insecticide toxicity bioassays 
The toxicity of the three insecticides, CPE, MFZ and FLV, was 
determined by administering them in varying concentrations of insecticides in 
artificial diets to newly hatched larvae. A series of doses of insecticides (CPE, 10, 20, 
50, 100, 300 and 500 ng/g; FLV, 0.2, 0.5, 1, 3 and 5 μg/g; MFZ, 20, 50, 100, 300 and 
500 ng/g) were dissolved in MeOH and added to the artificial diet; for controls, an 
equal amount of MeOH was added to the artificial diet. For each bioassay series, 
twenty newly hatched larvae (collected between 0-12 hr after hatching) were raised 
on each single dose of insecticide and their mortality was recorded at 24 hr and 48 hr. 
The larvae that did not move when touched with a soft brush were considered as dead. 
The median lethal concentration (LC50) at 24 hr and 48 hr was calculated using the 
Probit Analysis function in SPSS v17 software (SPSS Inc., Chicago, IL).  
2.4 Synergist assays 
For the synergist bioassays, the three insecticides (CPE, FLV, MFZ), XAN 
and AFB1 were supplemented with MYR and PBO to determine the synergistic 
effects on NOW larvae. The final concentrations of the synergists MYR (25 μg/g) 
and PBO (200 μg/g) were determined to be nontoxic for first instar larvae. The 
concentrations selected for the insecticides and XAN caused 30-70% mortality to the 
newly hatched larvae after 36 hr. The dose of AFB1 (50 μg/g) was sublethal to larvae. 
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For the insecticide assays, the diets containing 25 μg/g CPE, 2 μg/g FLV or 
50 ng/g MFZ in the presence or absence of MYR (25 μg/g) or PBO (200 μg/g) were 
fed to the larvae. Because high concentrations of XAN stock dissolved in MeOH 
crystallized immediately after being added to the artificial diets and made 
homogeneous incorporation difficult, XAN powder was mixed with the sucrose to be 
added to the diet, ground with a mortar and pestle until it was homogeneous, and then 
added directly to the diets to a final concentration of 2 mg/g XAN. The controls for 
the XAN assays were plain diet, plain diet with MeOH, and plain diet supplemented 
with 25 μg/g MYR or 200 μg/g PBO. Mortality was recorded daily until more than 
80% of the treated insects were dead. For AFB1 assays, caterpillars were placed on 
diets containing 0.5% DMSO (control), 25 µg/g MYR, 200 μg/g PBO, 50 µg/g AFB1, 
50 µg/g AFB1 + 200 μg/g PBO or 50 µg/g AFB1 + 25 μg/g MYR. Larval mortality 
was recorded every day and the larvae were weighed after 24 days. Each bioassay 
included 20 first instar larvae subjected to a single concentration of these chemicals 
and all bioassays were repeated at least three times.  
2.5 Statistical analysis  
The mean mortalities and errors at the different time intervals were 
calculated and differences between the chemical alone and the chemical administered 
with PBO or MYR were determined by the post hoc LSD test that was part of the 
one-way analysis of variance (one-way ANOVA) module in the SPSS v17 software. 
Differences among mean larval weights were also compared in the AFB1 assays 
using the post hoc LSD test following one-way analysis of variance (ANOVA).  
3 Results  
3.1 Comparison of the toxicity of the insecticides  
The insecticides examined in this study exhibited differential toxicity to 
NOW. Among pyrethroids, CPE is 26-fold more toxic at 24 hr and 56-fold more toxic 
at 48 hr than FLV. The ecdysteroid agonist insecticide, MFZ, began to cause mortality 
at 36 hr when the larvae started molting. The toxicity at 48 hr was lower than CPE 
(0.17-fold) and higher than FLV (9.6-fold) (Table 2).  
3.2 Synergistic effects  
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The P450 inhibitors PBO and MYR were applied to test synergistic 
effects on the toxicity of the insecticides, phytochemicals and aflatoxins to the newly 
hatched NOW larvae. Both PBO and MYR synergized CPE; PBO significantly 
increased larval mortality starting from 12 hr and MYR significantly increased 
mortality starting from 4 days. For the other pyrethroid insecticide, FLV, only PBO 
continuously showed significant synergistic effects over time (Fig. 1B). MFZ, a 
substituted dibenzoylhydrazine, affects the molting process and causes toxicity to the 
insects during larval development (Carlson et al., 2001). Following the addition of 25 
μg/g MYR and 200 μg/g PBO to diets containing 50 ng/g MFZ, there was no 
significant increase in mortality (Fig. 1C).  
Following range finding assays, a 2 mg/g dose of XAN was selected 
because it caused at least 20% mortality of first instar larvae after 2 days. To test 
synergism of XAN with PBO and MYR, diets containing 2 mg/g XAN were 
supplemented with 25 μg/g MYR or 200 μg/g PBO. The results showed that PBO 
significantly increased mortality of XAN after 3 days (Fig. 1D). The diets with XAN 
alone caused 16% and 30% mortality, respectively, after 3 and 4 days, in contrast 
with 32% and 61% for XAN plus PBO (P =0.02 for the third day, P =0.0001 for the 
fourth day). MYR might slightly synergize XAN because mortality caused by XAN 
plus MYR was consistently higher over time, but a significant synergistic effect was 
recorded only on the seventh day, when the mortality of the larvae treated with XAN 
plus MYR (83%) was higher than that of the larvae treated with XAN (65%) (p 
=0.01).   
Bioassays in which effects on larval mortality are recorded as an indicator 
of toxicity are not as robust in testing the synergistic effects on AFB1 toxicity to 
NOW because these larvae can tolerate extremely high levels of aflatoxins (Niu et al., 
2009). Even a massive dose of AFB1 (over 50 μg/g) did not kill the insects 
immediately and many larvae survived long after this initial exposure to AFB1. In 
addition to measuring mortality, larval weights were recorded as a supplemental 
indicator of AFB1 toxicity, in treatments where either 25 μg/g MYR or 200 μg/g PBO 
along with 50 μg/g AFB1 were added to the diet, and daily mortality and larval 
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weights after 24 days were compared. The results (Table 3) indicate that neither 
PBO+AFB1 nor MYR+AFB1 caused any significant increase in mortality or 
significant decrease in larval weight.  
4. Discussion 
A combination of chemical sprays, biological controls and cultural control  
is used to minimize NOW damage in orchards in California. Pyrethroid insecticides, 
such as permethrin, bifenthrin, beta cyfluthrin and lambda cyhalothrin have been 
widely used in controlling infestations in pistachios, with no insecticide resistance yet 
reported for NOW. In this study we demonstrate that CPE can also effectively kill 
NOW larvae, and that FLV, which is frequently used to control aphids and mites in 
beehives (Johnson et al., 2006) and is not generally as toxic as CPE, can also 
effectively kill NOW larvae. MFZ, frequently used in almonds because it is an insect 
growth regulator that inhibits the larval molting process in target lepidopteran pests  
and is not harmful to beneficial insects and mites (Carlson et al., 2001), can 
effectively cause mortality in NOW larvae, although mortality occurs at a slower rate 
than CPE and FLV.   
Pyrethroid insecticides are known to be metabolized by detoxificative 
P450s and esterases in several insect species (Ishaaya 1993; Pilling et al., 1995; 
Johnson et al., 2006). In our studies, PBO, a well-known synergist that inhibits many 
(but not all) insect P450s, significantly synergized the toxicity of both pyrethroids 
(CPE and FLV) to NOW larvae. MYR, a natural phytochemical previously 
demonstrated to be capable of synergizing P450-mediated detoxification, increased 
the toxicity of only a single insecticide tested, CPE. These data reaffirm that P450s 
are involved in metabolism of the pyrethroid insecticides by NOW and that inhibition 
of P450s can be a management strategy to increase the efficacy of the pyrethroid 
insecticides to control NOW. Because MYR also can inhibit growth of A. flavas and 
decrease formation of aflatoxins (Razzaghi-Abyaneh et al., 2007), it would appear to 
be an exceptional candidate for NOW control. It is relatively non-toxic to humans, it 
synergizes an insecticide (CPE), and it can help to reduce aflatoxin contamination in 
orchards. 
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Mosallanejad and Smagghe (2009) recently reported that PBO 
significantly synergized MFZ toxicity to the resistant strain of the cotton leafworm 
Spodoptera littoralis. In this particular study, the P450 activity in the resistant strain 
was increased 2.1-fold compared with the susceptible strain and it may be that the 
reported synergistic effects in the resistant strain were caused by inhibition of MFZ 
oxidation. Differences between S. littoralis and NOW larvae may exist if P450s are 
not the main detoxification system for MFZ in NOW or if the specific P450s 
mediating this process are resistant to PBO inhibition. Future research should 
examine the inhibitors of other detoxification enzymes, such as glutathione 
S-transferases or hydrolases, to determine if these pathways are involved in MFZ 
detoxification.  
When AFB1 and XAN were evaluated, neither the naturally occurring 
essential oil constituent MYR nor the synthetic compound PBO synergized the 
toxicity of AFB1. This finding suggests that NOW may rely mainly on detoxification 
systems other than P450s to metabolize AFB1. Alternatively, this absence of 
synergism may be due to the fact that the NOW may possess excess metabolic 
capacity for detoxifying AFB1, which is frequently encountered in the 
fungus-contaminated hosts utilized by this lepidopteran. In contrast, both PBO and 
MYR synergized XAN toxicity. Although the mechanisms by which the NOW 
tolerates XAN and other furanocoumarins are as yet unknown, detoxification by 
P450s is a distinct possibility because these compounds are metabolized by P450s in 
three different families of lepidopterans (Oecophoridae, Noctuidae, Papilionidae). 
CYP6AB11 from NOW, expressed heterologously in a baculovirus system, is capable 
in vitro of metabolizing imperatorin, a furanocoumarin found in some species in the 
Rutaceae, a family containing some reported hosts of this species (Niu 2010). MYR 
is also known to synergize furanocoumarin toxicity in several other lepidopterans 
species (Berenbaum and Neal, 1985; Neal, 1989; Neal and Berenbaum, 1989; Yu and 
Hsu, 1993; Mao et al., 2008). In view of these findings, and in view of the limited 
availability of environmentally safe synthetic insecticides for sustainable 
management of NOW in almond organic orchards, MYR should be explored further 
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as a field treatment to reduce survival of this pest species and aflatoxin contamination 
in orchard situations. 
Refernces 
Belzile AS Majerus SL, Podeszfinski C, Guillet G, Durst T, Arnason JT, 2000. 
Dillapiol derivatives as synergists: Structure-activity relationship analysis. 
Pesticide Biochemistry & Physiology, 66:33-40. 
 
Berenbaum M, Neal JJ, 1985. Synergism between myristicin and xanthotoxin, a 
naturally co-occurring plant toxicant. J Chem Ecol., 11: 1349–58. 
 
Campbell BC Molyneux RJ. Schatzki TF, 2003 Current research on reducing  pre- 
and post-harvest aflatoxin contamination of US almond, pistachio, and 
walnut. Journal of Toxicology Toxin Reviews, 22: 225-66.  
 
Carlson GR, Dhadialla TS, Hunter R, Jansson RK, Jany CS, Lidert Z, Slawecki RA, 
2001.The chemical and biological properties of methoxyfenozide, a new 
insecticidal ecdysteroid agonist. Pest Manag Sci., 57:115-9. 
 
Connell JH. 2001. Leading edge of plant protection for almond. Hort Technology, . 
12:619-622. 
 
Food and Drug Administration, 1996. Compliance Policy Guides Manual. Sub 
chapter 570, 500, 299. 
 
Higbee BS, Siegel JP, 2009.  New navel orangeworm sanitation standards could 
reduce almond damage. Calif Agric., 63: 24-28.   
 
Ishaaya I, 1993. Insect detoxifying enzymes: their importance in pesticide synergism 
and resistance. Arch Insect Biochem Physiol. 22:263-76. 
 
Johnson RM, Wen Z, Schuler MA, and Berenbaum MR, 2006. Mediation of 
pyrethroid insecticide toxicity to honey bees (Hymenoptera: Apidae) by 
cytochrome P450 monooxygenases. J. Econ. Entomol., 99: 1046-50. 
 
Finney GL and Brinkman D, 1967. Rearing the navel orangeworm in the laboratory. J. 
Econ. Entomol., 60:1109-11.  
 
Lee SE and Campbell BC, 2000 In vitro metabolism of aflatoxin B-1 by larvae of 
navel orangeworm, Amyelois transitella (Walker) (Insecta, lepidoptera, 
Pyralidae) and codling moth, Cydia pomonella (L.) (Insecta, Lepidoptera, 
Tortricidae). Archives of Insect Biochemistry & Physiology, 45:166-174. 
 
Li X, Baudry J, Berenbaum MR, Schuler MA, 2004.Structural and functional 
127 
divergence of insect CYP6B proteins: From specialist to generalist 
cytochrome P450.Proc Natl Acad Sci. U S A., 101:2939-44. 
 
Lichtenstein EP, Casida JE, 1963. Myristicin, an insecticide and synergist occurring 
naturally in the edible parts of parsnips. J Agric Food Chem., 11: 410–5.  
 
Mao W, Rupasinghe S, Zangerl AR, Schuler MA, Berenbaum MR, 2006. Remarkable 
substrate-specificity of CYP6AB3 in Depressaria pastinacella, a highly 
specialized caterpillar. Insect Mol Biol., 15:169-79. 
 
Mao W, Zangerl AR, Berenbaum MR, Schuler MA, 2008.Metabolism of myristicin 
by Depressaria pastinacella CYP6AB3v2 and inhibition by its metabolite. 
Insect Biochem Mol Biol., 38:645-51. 
 
Molyneux RJ, Mahoney N, Kim JH, Campbell BC, 2007. Mycotoxins in edible tree 
nuts. Int J Food Microbiol., 119:72-8.  
 
Mosallanejad H, Smagghe G, 2009. Biochemical mechanisms of methoxyfenozide 
resistance in the cotton leafworm Spodoptera littoralis. Pest Manag Sci., 
65:732-6. 
 
Murray RDH, Mendez J, Brown SA, 1982. The Natural Coumarins. Wiley, 
Chichester, UK. 
 
Neal JJ, 1989. Myristicin, safrole, and fagaramide as phytosynergists of xanthotoxin. 
J. Chem. Ecol. 15: 309–315. 
 
Neal JJ, Berenbaum MR, 1989. Decreased sensitivity of mixed-function oxidases 
from Papilio polyxenes to inhibitors in host plants. J Chem Ecol., 15: 
439–446. 
 
Niu G, Siegel J, Schuler MA, Berenbaum MR, 2009. Comparative toxicity of 
mycotoxins to navel orangeworm (Amyelois transitella) and corn 
earworm (Helicoverpa zea). J Chem Ecol., 35: 951-7. 
 
Nogueira JH, Gonçalez E, Galleti SR, Facanali R, Marques MO, Felício JD, 2010. 
Ageratum conyzoides essential oil as aflatoxin suppressor of Aspergillus 
flavus. Int J Food Microbiol., 137:55-60. 
 
Pilling ED, Bromley-Challenor KAC, Walker CH, and Jepson CP, 1995. Mechanism 
of synergism between the pyrethroid insecticide lambda-cyhalothrin and 
the imidazole fungicide prochloraz, in the honeybee (Apis mellifera L.). 
Pestic Biochem. Physiol., 51: 1-11. 
 
128 
Razzaghi-Abyaneh M. Yoshinari T. Shams-Ghahfarokhi M. Rezaee MB. Nagasawa H. 
Sakudat S, 2007. Dillapiol and apiol as specific inhibitors of the 
biosynthesis of aflatoxin G(1) in Aspergillus parasiticus. Bioscience, 
Biotechnology & Biochemistry, 71:2329-32. 
 
Razzaghi-Abyaneh M, Shams-Ghahfarokhi M, Yoshinari T, Rezaee MB, Jaimand K, 
Nagasawa H, Sakuda S, 2008. Inhibitory effects of Satureja hortensis L. 
essential oil on growth and aflatoxin production by Aspergillus 
parasiticus. Int J Food Microbiol., 123:228-33.  
 
Razzaghi-Abyaneh M, Shams-Ghahfarokhi M, Rezaee M and Sakuda S, 2010. 
Natural aflatoxin inhibitors from medicinal plants mycotoxins in food, 
feed and bioweapons. Springer Berlin Heidelberg, 329-52.  
 
Rusul G, Marth EH, 1988. Food additives and plant components control growth and 
aflatoxin production by toxigenic aspergilli: a review. Mycopathologia, 
101:13-23.  
 
Shelton MD, Davis DW, 1994. Navel orangeworm (Lepidoptera: Pyralidae) 
development in sunburned walnuts. J Econo Entom., 87: 1062-69. 
 
Schatzki TF and Ong MS, 2000. Distribution of aflatoxin in almonds. 2. Distribution 
in almonds with heavy insect damage. J.Agric Food Chem., 48:489–492. 
 
Schatzki TF and Ong MS, 2001. Dependence of aflatoxin in almonds on the type and 
amount of insect damage. J Agric Food Chem, 49:4513–9. 
 
Shukla R, Kumar A, Singh P, Dubey NK, 2009. Efficacy of Lippia alba (Mill.) N.E. 
Brown essential oil and its monoterpene aldehyde constituents against 
fungi isolated from some edible legume seeds and aflatoxin B1 
production. Int. J Food Microbiol., 135:165-70.  
 
Singh P, Kumar A, Dubey NK, Gupta R, 2009. Essential oil of Aegle marmelos as a 
safe plant-based antimicrobial against postharvest microbial infestations 
and aflatoxin contamination of food commodities. J. Food Sci. 74:302-7. 
 
Wagacha JM, Muthomi JW, 2008. Mycotoxin problem in Africa: current status, 
implications to food safety and health and possible management strategies. 
Int. J. Food Microbiol., 124:1-12.  
 
Wen Z, Rupasinghe S, Niu G, Berenbaum MR, Schuler MA, 2006. CYP6B1 and 
CYP6B3 of the black swallowtail (Papilio polyxenes): adaptive evolution 
through subfunctionalization. Mol Biol Evol., 23:2434-43.  
 
129 
Widstrom NW, 1979. The role of insects and other plant pests in aflatoxin 
contamination of corn, cotton, and peanuts—a review. J. Environ. Qual., 
8: 5-11. 
 
Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D, 2004. Human 
aflatoxicosis in developing countries: a review of toxicology, exposure, 
potential health consequences, and interventions. Am J Clin Nutr., 
80:1106-22.  
 
Yu SJ, Hsu ER, 1993. Induction of detoxification enzymes in phytophagous insects: 
roles of insecticide synergists, larval age, and species. Archives of Insect 































































Table 2. LC50 of insecticides for first instar Amyelois transitella. Mortality of first 
instars treated with varying concentrations of insecticides was recorded after 24 and 
48 hours. All bioassays were repeated at least three times and the LC50 (the 
concentration of the insecticide in the diets that causes 50% mortality at the specified 
time) was calculated with the Probit analysis function from SPSS v17 software (SPSS 
Inc., Chicago, IL).  
 
 
Insecticides 24h LC50 
(95% Confidence 
Limits )  µg/g 
48h LC50 
(95% Confidence 
Limits )  µg/g 
 τ-fluvalinate 1.9 (1.2-3.0) 0.73 (0.45-1.2) 
α-cypermethrin 0.072(0.045-0.11) 0.013 (0.007-0.023) 



















Table 3. Bioassays of potential synergists of aflatoxin B1 toxicity to first instar 
Amyelois transitella. Effects of MYR and PBO on the toxicity of AFB1 were 
quantified by measuring larval weight after 24 days. First instars received plain diet 
containing 0.5% DMSO, 50 µg/g AFB1, 200 µg/g PBO, 25 µg/g MYR, 50 µg/g 
AFB1 plus 200 µg/g PBO or 25 µg/g MYR. Mean survivorship or larval weight was 
compared between the treatment of 50 µg/g AFB1 and that of 25ng/g MYR+AFB1 or 
200ng/g PBO+AFB1 with LSD tests of one-way analysis of variance (ANOVA) and 
no significant difference was found. 
 
 
 Survivorship (%) Larval weight (mg) on 
day 24 
plain diet 89±10 91±16 
0.25% DMSO 90±7 87±22 
50 µg/g AFB1 88±13 17±8 
25ng/g MYR+AFB1 83±7 19±12 
200ng/g PBO+AFB1 74±15 17±13 
25ng/g MYR 83±10 89±20 


































Fig. 1 Synergistic effects of piperonyl butoxide (PBO) and myristicin (MYR) on 
insecticide and xanthotoxin (XAN) toxicity to navel orangeworm. Fig. 1A Effects 
of PBO and MYR on the mortality of newly hatched larvae exposed to cypermethrin 
(CPE) (Fig. 1A), fluvalinate (FLV) (Fig. 1B), methoxyfenozide (MFZ) (Fig. 1C) and 
XAN (Fig. 1D) were tested. Larvae were fed with artificial diets containing 25 ng/g 
CPE, 2 μg/g FLV, 50 ng/g MFZ or 2 mg/g XAN supplemented with or without 25 
μg/g MYR or 200 μg/g PBO. Plain diet and diets containing the synergists alone or 
an equal amount of MeOH were used as controls. All of the bioassays were repeated 
at least three times. The mean mortality was compared between treatments with LSD 































Fig. 1B. Effects of PBO and MYR on the mortality of newly hatched larvae 






























Fig.1C. Effects of PBO and MYR on the mortality of newly hatched larvae 


































Fig.1D. Effects of PBO and MYR on the mortality of newly hatched larvae 
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